IN FORCE Advance Authorisation

DGFT Minutes

Reliability

In force — no superseding record on file.

Document text

UDIN00566232AM26

Government of India / भारत सरकार

Ministry of Commerce and Industry / वािणज्य और उद्योग मंत्रालय Department of Commerce / वािणज्य िवभाग

Directorate General of Foreign Trade, Delhi / िवदेश व्यापार महािनदेशालय, िदल्ली

VANIJYA BHAWAN, AKBAR ROAD, CENTRAL DELHI, DELHI, 110011 / वािणज्य भवन, अकबर रोड, नई िदल्ली Email Office : egtf-dgft@gov.in , Phone Office : 011-23062777

MINUTES OF THE NORMS COMMITTEE- III

MINUTES OF MEETING

Meeting No - NC/3/MEET/Jan/202526/12 Meeting Date - 15/01/2026

Minutes of the Norms Committee–3 Meeting No.NC/3/MEET/Jan/202526/12 dated 15/01/2026 (actually held on 22/01/2026) under the Chairmanship of Shri Rakesh Kumar, Addl. DGFT for considering the cases/issues under Duty Exemption Scheme (Chapter-4) of the Foreign Trade Policy, 2023 pertaining to Chemical and Allied products falling under Chapter 29 and 30.

    The following members were present in the Meeting:-

Sl. No.	Name & Designation	Department
1	Shri Dinesh Narain Mathur, Technical Expert	Consultant (Pharma)
2	Shri Shaish Kumar, Technical Expert	Consultant (Chemical)
3	Shri Raman Kumar, Deputy DGFT	DGFT (HQ)
4	Smt. Skina Rani, FTDO	DGFT (HQ)

    The Norms Committee has taken decisions only with respect to technical aspect/ wastage norms.

Signature Not Verified Signature Not Verified Digitally Signed. Digitally signa, Name: RAMAN KUMAR( Deputy Name: RAMAN KUJAAR( Deputy DGFT ) DGFT Date: 25-Feb-2026 07:20:06 Date: )25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) Location:Reason: ramankajmar@nic.inDGFTTHQ)

This document has been digitally signed by Raman Kumar, Deputy DGFT,DGFT(HQ) on 25-Feb-2026.

UDIN00566232AM26

mankumar@nic.in Location: DGFT(HQ) Location:Reason: ramankajmar@nic.inDGFTTHQ)

This document has been digitally signed by Raman Kumar, Deputy DGFT,DGFT(HQ) on 25-Feb-2026.

UDIN00566232AM26

While redeeming the application, RAs should check that the applicant has fulfilled all requirements as prescribed in policy/procedure, including those in notifications, public notices and policy circulars issued from time to time or any other provisions under FTP/HBP for issuance of Advance Authorization and regularisation of the case.

    RAs shall ensure compliance with SION, General Notes and Chapter Notes wherever applicable.

    RAs shall also ensure that authorization is issued or redeemed based on the wastages/consumption as ratified by the Committee or as per wastages claimed in the application, whichever is less. In this regard, full compliance with the provisions of Para 4.12 of FTP, Para 4.16, Para 4.21, and Para 4.51 of HBP shall be made.

Signature Not Verified

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

Case Details and Decision(s):

Case No.	1 / NC/3/MEET/Jan/202526/12
Case Status	Case Approved
Party Name	ANUGRAH INORG PRIVATE LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00000596AM26
RA File Number	NA
Licence No and<br>Date	NA
Norms Committee Decision:<br>The Committee considered the request of firm for fixation of ad-hoc norms to enable them to obtain Advance<br>Authorization from concerned RA and it was decided to fix ad-hoc norms as per details given below or as applied by<br>the firm, whichever is less:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>Monochloro Acetic Acid<br>1 kg.<br>1<br>Acetic Acid Glacial /Acetic Acid<br>0.658 kg.<br>RA concerned may take further necessary action as per above decision of NC.

Case No.	2 / NC/3/MEET/Jan/202526/12
Case Status	Case Approved
Party Name	MACSON PRODUCTS
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00001280AM26
RA File Number	NA
Licence No and<br>Date	NA
Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms to facilitate the issuance of<br>Advance Authorization by the concerned Regional Authority. After due deliberation, the Committee<br>decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority or as applied<br>for by the firm,whichever is less, as per the details indicated below.:-

tee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority or as applied for by the firm,whichever is less, as per the details indicated below.:-||

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

Export Product	Qty.	Sl. No.	Import Items	Qty. allowed.
Schaeffers Acid	1 kg.	1	Beta Naphthol	0.74 kg.

Note: Further, the NC has recommended the creation of a new Standard Input Output Norm (SION) for the above export product.

RA concerned may take further necessary action as per above decision of NC.

No<br>ex<br>R	Export Product	Export Product	Qty.		Sl. No.	Import Items	Qty. allowed.
	Schaeffers Acid		1 kg	.	1	Beta Naphthol	0.74 kg.
	te:Further, the NC has recommende<br>port product.<br>A concerned may take further nec			d the creatio<br>essary acti	n of a new	Standard Input Output Norm (SION)	for the above
					on as per	above decision of NC.

Case No.		3 / NC/3/MEET/Jan/202526/12
Case Status		Case Approved
Party Name		ENCUBE ETHICALS PRIVATE LIMITED

Meeting Number<br>and Date		NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number		HQRNORM APPLY 00001510AM26
RA File Number		NA

|| |Meeting Number and Date||||NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|||||||||||| |HQ File Number||||HQRNORM APPLY 00001510AM26|||||||||||| |RA File Number||||NA|||||||||||| ||||||||||||||||| |Licence No and Date||||NA|||||||||||| ||||||||||||||||| |Norms Committee||||Decision:|||||||||||| ||||||||||||||||| |The Committee e Authorization by t ||||xamined the request of the firm for fixation of ad-hoc norms to facilitate the issuance of Advance he concerned Regional Authority. After due deliberation, the Committee decided to fix the ad-hoc |||||||||||| |norms on the basis ||||of inputs received from the Technical Authority or as applied for by the firm,whichever is less, as |||||||||||| |per the details indi||||cated below.:-|||||||||||| ||Sl. No.||Expor|t Product|||||||||||Quantity| ||||||||||||||||| ||1||Medical Creams & Ointments(ESTRADIOL GEL 0.06% 50 gm Pump Wt: 2750 Kgs (Net Cont: ESTRADIOL 1.65 Kgs, ETHANOL 1147.58 Kgs, CARBOPOL 28.6 Kgs, TROLAMINE 27.50 Kgs, WHITE CAP, WHITE BOTTLE, WHITE PUMP 55000 Nos EACH))|||||||||||| 1 Number| ||2||Medical Creams & Ointments(ESTR ||||||ADIOL GEL 0.1% , 1.25 gm Sachet Wt: 750 Kgs ||||||1 Number| ||||(Net Cont: ESTRADI TROLAMINE 2.10 K|||OL 0.75 Kgs, E gs, PROPYLE|||THANO NE 90 Kg||412.50 Kgs, CARBOPOL 9.75 Kgs, s))||||| ||3||||||||||||||| ||||Medical Creams & Oi (Net Cont: ESTRADI TROLAMINE 0.42 K|||ntments(ESTR OL 0.15 Kgs, E gs, PROPYLE|||ADIOL G THANOL ||EL 0.1% , 0.25 gm Sachet Wt: 150 Kgs 82.50 Kgs, CARBOPOL 1.95 Kgs, ||||1 Number|

(Net Cont: ESTRADI TROLAMINE 0.42 K|||ntments(ESTR OL 0.15 Kgs, E gs, PROPYLE|||ADIOL G THANOL ||EL 0.1% , 0.25 gm Sachet Wt: 150 Kgs 82.50 Kgs, CARBOPOL 1.95 Kgs, ||||1 Number| ||||||||||NE 18 Kg||s))||||| |||||||||||||||||

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

4	Medical Creams & Ointments(ESTRADIOL GEL 0.1% , 1 gm Sachet Wt: 600 Kgs (Net	1 Number
	Cont: ESTRADIOL 0.6 Kgs, ETHANOL 330.00 Kgs, CARBOPOL 7.8 Kgs,
	TROLAMINE 1.68 Kgs, PROPYLENE 72 Kgs))
5	Medical Creams & Ointments(ESTRADIOL GEL 0.1% , 0.75 gm Sachet Wt: 450 Kgs	1 Number
	(Net Cont: ESTRADIOL 0.45 Kgs, ETHANOL 247.50 Kgs, CARBOPOL 5.85 Kgs,
	TROLAMINE 1.26 Kgs, PROPYLENE 54 Kgs))
6	Medical Creams & Ointments(ESTRADIOL GEL 0.1% , 0.50 Gm Sachet Wt: 300 Kgs	1 Number
	(Net Cont: ESTRADIOL 0.30 Kgs, ETHANOL 165 Kgs, CARBOPOL 3.90 Kgs,
	TROLAMINE 0.84 Kgs, PROPYLENE 36 Kgs))

Sl. No.	Import Product	Quantity allowed.
1	Relevant Bulk Drugs	Net content in the export product plus 2% wastage.
2	Relevant Excipients	Net content in the export product plus 2% wastage.
3	Relevant Packaging Material	Relevant as per Packing Policy & General Notes.

Note:

i. The firm will declare net weight of import items (Relevant Bulk Drugs and Excipients) in export to the RA concerned for redemption.

Case No.	4 / NC/3/MEET/Jan/202526/12
Case Status	Case Approved
Party Name	TROIKAA PHARMACEUTICALS LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00001967AM25
RA File Number	NA
Licence No and<br>Date	NA
Norms Committee Decision:

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

The Committee considered the case as per agenda and taking cue from the earlier decision for same export product/import item in meeting No.NC/3/MEET/Mar/202425/18 dated 17/03/2025 against DGFT (HQ) File No.HQRNORMAPPLY00002512AM25, it was decided to fix ad-hoc norms under Para 4.07 of HBP Vol. I as per details given below or as applied by the firm, whichever is less:-

Export Product	Qty.	Sl. No.	Import Items	Qty. allowed.
Drug<br>Formulations<br>Injections<br>(ampoules /vials above 10 ml.)<br>(Propofol<br>Injection)<br>(20<br>ml.<br>Injection)	<br> <br> <br>1 Number	1	Propofol	210.00 mg.
		2	E 80 (Egg Lecithin)	240.00 mg.
		3	Sodium Oleate B	6.00 mg.
		4	Purified Soyabean Oil 700	2000.00 mg.
		5	Rubber stopper	Relevant, as per<br>Packing Policy and<br>General Notes.

mg.| |||2|E 80 (Egg Lecithin)|240.00 mg.| |||3|Sodium Oleate B|6.00 mg.| |||4|Purified Soyabean Oil 700|2000.00 mg.| |||5|Rubber stopper|Relevant, as per Packing Policy and General Notes.|

Case No.	5 / NC/3/MEET/Jan/202526/12
Case Status	Case Approved
Party Name	SUPRIYA LIFESCIENCE LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00003179AM26
RA File Number	NA
Licence No and<br>Date	NA
Norms Committee Decision:<br>The Committee considered the case as per agenda and taking cue from the earlier decision for same export<br>product/import item in meeting No.7/82-ALC4/2019 dated 06/09/2019 against advance authorization<br>No.05104092104 dated 07/01/2019, it was decided to fix ad-hoc norms under Para 4.07 of HBP Vol. I as<br>per details given below or as applied by the firm, whichever is less:-

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

as applied by the firm, whichever is less:-||

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

Export Product	Qty.	Sl. No.	Import Items	Qty. allowed.
Pentoxifylline	1 kg.	1	Theobromine	0.84 kg.
		2	6 Chloro 2 Hexanone	0.72 kg.
		3	Dimethyl Formamide	0.75 kg.
		4	Pottasium Carbonate	0.43 kg.
		5	Methanol	0.75 kg.
		6	Acticarbone	0.0117 kg.

Case No.	Case No.	6 / NC/3/MEET/Jan/202526/12	6 / NC/3/MEET/Jan/202526/12	6 / NC/3/MEET/Jan/202526/12	6 / NC/3/MEET/Jan/202526/12	6 / NC/3/MEET/Jan/202526/12
Case Status		Case Approved
Party Name		AASTRID LIFE SCIENCES PRIVATE LIMITED
Meeting Number and<br>Date		NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number		HQRNORM APPLY 00004376AM26
RA File Number		NA
Licence No and Date		NA
Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms to facilitate the issuance of Advance<br>Authorization by the concerned Regional Authority.

| |Norms Committee Decision: The Committee examined the request of the firm for fixation of ad-hoc norms to facilitate the issuance of Advance Authorization by the concerned Regional Authority. After due deliberation, the Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority or as applied for by the firm,whichever is less, as per the details indicated below.:- Export Product Qty. Sl. No. Import Items Qty. allowed. 1 Allyl Alcohol 0.375 kg. 2 Cyclododecanone 1.117 kg. Oxacyclohexadecen-2-one (Habanopaz, Habanolide) 1 kg.||||||| ||Export Product||Qty.|Sl. No.|Import Items|Qty. allowed.| ||Oxacyclohexadecen-2-one (Habanopaz, Habanolide)||1 kg.|1|Allyl Alcohol|0.375 kg.| |||||2|Cyclododecanone|1.117 kg.|

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

3<br>Di tertiary butyl peroxide<br>0.380 kg.<br>4<br>Dimer Acid<br>0.095 kg.<br>5<br>Butyl Acetate<br>0.256 kg.<br>RA concerned may take further necessary action as per above decision of NC.			3	Di tertiary butyl peroxide	0.380 kg.
			4	Dimer Acid	0.095 kg.
			5	Butyl Acetate	0.256 kg.

erned may take further necessary action as per above decision of NC.			3	Di tertiary butyl peroxide	0.380 kg.
			4	Dimer Acid	0.095 kg.
			5	Butyl Acetate	0.256 kg.

Case No.	Case No.	7 / NC/3/MEET/Jan/202526/12	7 / NC/3/MEET/Jan/202526/12	7 / NC/3/MEET/Jan/202526/12
Case Status		Case Approved
Party Name		TROIKAA PHARMACEUTICALS LIMITED
Meeting Number<br>and Date		NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number		HQRNORM APPLY 00004572AM26
RA File Number		NA
Licence No and<br>Date		NA
Norms Committee Decision:<br>The Committee considered the case as per agenda and taking cue from the earlier decision for same export<br>product/import item in meeting No.NC/3/MEET/Mar/202425/18 dated 17/03/2025 against DGFT (HQ)<br>File No.HQRNORMAPPLY00002512AM25, it was decided to fix ad-hoc norms under Para 4.07 of HBP<br>Vol. I as per details given below or as applied by the firm, whichever is less:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>1<br>Propofol<br>210.00 mg.<br>2<br>E 80 (Egg Lecithin)<br>240.00 mg.<br>3<br>Sodium Oleate B<br>6.00 mg.<br>4<br>Purified Soyabean Oil 700<br>2000.00 mg.<br>Drug<br>Formulations<br>Injections<br>(ampoules /vials above 10 ml.)<br>(Propofol<br>Injection)<br>(20<br>ml.<br>Injection)<br>1 Number<br>5<br>Rubber stopper<br>Relevant, as per<br>Packing Policy and<br>General Notes.
	Export Product		Qty.	**Sl.

ml.) (Propofol Injection) (20 ml. Injection) 1 Number 5 Rubber stopper Relevant, as per Packing Policy and General Notes.||||||| ||Export Product||Qty.|Sl. No.|Import Items|Qty. allowed.| ||Drug Formulations Injections (ampoules /vials above 10 ml.) (Propofol Injection) (20 ml. Injection)|| 1 Number|1|Propofol|210.00 mg.| |||||2|E 80 (Egg Lecithin)|240.00 mg.| |||||3|Sodium Oleate B|6.00 mg.| |||||4|Purified Soyabean Oil 700|2000.00 mg.| |||||5|Rubber stopper|Relevant, as per Packing Policy and General Notes.|

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

Case No.	8 / NC/3/MEET/Jan/202526/12
Case Status	Case Deferred
Party Name	B G P HEALTHCARE PRIVATE LIMITED

Meeting Number
<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00004745AM26
RA File Number	NA
Licence No and
<br>Date	NA
Norms Committee	Decision:
The committee con<br>	sidered the case as per the agenda and noted that the firm has requested prior fixation of norms under<br>
Para 4.06 of HBP-2023. After examination, it was observed that the firm has not furnished the requisite technical details<br>as prescribed in Annexture to Appendix 4E.

r fixation of norms under | |Para 4.06 of HBP-2023. After examination, it was observed that the firm has not furnished the requisite technical details as prescribed in Annexture to Appendix 4E. After detailed deliberations and in view of the recommendations of the Technical Authority, the Committee decided to ask the firm to furnish the following documents: Copy of Drug Manufacturing Licence (DML) for the export item. 1. Complete and Balance chemical reaction showing utilization of import item. 2. Certificate of Analysis (CoA) of export item. 3.|| |||



Case No.	9 / NC/3/MEET/Jan/202526/12

Case Status	Case Approved

Party Name	FINE ORGANIC INDUSTRIES LIMITED
Meeting Number<br>	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
and Date

HQ File Number	HQRNORM APPLY 00004795AM26

RA File Number	NA
Licence No and<br>	NA
Date
Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms to facilitate the issuance of Advance<br>Authorization by the concerned Regional Authority. After due deliberation, the Committee decided to fix the ad-hoc<br>norms on the basis of inputs received from the Technical Authority or as applied for by the firm,whichever is less, as<br>per the details indicated below.:-

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

as per the details indicated below.:-|| |||

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>1<br>Hydrogenated Palm Stearin<br>0.87 kg.<br>Monoglyceride (PS)<br>1 kg.<br>2<br>Refined Glycerine<br>0.180 kg.<br>RA concerned may take further necessary action as per above decision of NC.	Export Product	Qty.	Sl. No.	Import Items	Qty. allowed.
	Monoglyceride (PS)	1 kg.	1	Hydrogenated Palm Stearin	0.87 kg.
			2	Refined Glycerine	0.180 kg.

Case No.	10 / NC/3/MEET/Jan/202526/12
Case Status	Case Deferred
Party Name	BIOLOGICAL E. LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00005879AM25
RA File Number	NA
Licence No and<br>Date	NA
Norms Committee Decision:<br>As per advice ot technical authority (DBT) firm was asked to attend personal hearing through VC to explain<br>their case. However the personal hearing could not be conducted due to technical issues beyond control. In<br>view of this the Committee decided to provide another opportunity and to conduct the personal hearing<br>through video conference in the ensuing meeting

to technical issues beyond control. In view of this the Committee decided to provide another opportunity and to conduct the personal hearing through video conference in the ensuing meeting||

Case No.	11 / NC/3/MEET/Jan/202526/12
Case Status	Case Deferred
Party Name	KEVA FRAGRANCES PRIVATE LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM REVIW00001409AM25
RA File Number	039404000525 AM17
Licence No and<br>Date	0310807975/22/09/2016
Norms Committee Decision:

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

The Committee considered the case as per the agenda and observed that the nature of the export item, i.e., FLAVOURING ESSENCES , has not been clearly specified in the documents submitted, particularly whether it is intended for use as a perfumery item or as a flavouring agent, which is required for compliance with the provisions(list of ineligible item under self-declaration basis) of Para 4.11 of FTP

‑2023. After detailed deliberations and based on the recommendations of the Technical Authority, the Committee decided to direct the firm to furnish the following information:

(i) End use of export item supporting by technical documents.

sed on the recommendations of the Technical Authority, the Committee decided to direct the firm to furnish the following information:

(i) End use of export item supporting by technical documents.

Case No.	12 / NC/3/MEET/Jan/202526/12
Case Status	Case Deferred
Party Name	KEVA FRAGRANCES PRIVATE LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM REVIW00001412AM25
RA File Number	039404000762 AM18
Licence No and<br>Date	0310818348/09/01/2018
Norms Committee Decision:<br>The Committee considered the case as per the agenda and observed that the nature of the export item, i.e.,<br>FLAVOURING ESSENCES , has not been clearly specified in the documents submitted, particularly<br>whether it is intended for use as a perfumery item or as a flavouring agent, which is required for<br>compliance with the provisions(list of ineligible item under self-declaration basis) of Para 4.11 of FTP<br>‑2023.After detailed deliberations and based on the recommendations of the Technical Authority, the<br>Committee decided to direct the firm to furnish the following information:<br>(i) End use of export item supporting by technical documents

Case No.	13 / NC/3/MEET/Jan/202526/12
Case Status	Case Deferred
Party Name	KEVA FRAGRANCES PRIVATE LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

HQ File Number	HQRNORM REVIW00001454AM25
RA File Number	039404000390 AM19
Licence No and<br>Date	0310822723/31/07/2018
Norms Committee Decision:<br>The Committee considered the case as per the agenda and observed that the nature of the export item, i.e.,<br>FLAVOURING ESSENCES , has not been clearly specified in the documents submitted, particularly<br>whether it is intended for use as a perfumery item or as a flavouring agent, which is required for<br>compliance with the provisions(list of ineligible item under self-declaration basis) of Para 4.11 of FTP<br>‑2023.After detailed deliberations and based on the recommendations of the Technical Authority, the<br>Committee decided to direct the firm to furnish the following information:<br>(i) End use of export item supporting by technical documents

the recommendations of the Technical Authority, the Committee decided to direct the firm to furnish the following information: (i) End use of export item supporting by technical documents||

Case No.	14 / NC/3/MEET/Jan/202526/12
Case Status	Case Approved
Party Name	JODAS EXPOIM PRIVATE LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM REVIW00002022AM25
RA File Number	052304000507 AM19
Licence No and<br>Date	0510409676/15/02/2019
Norms Committee Decision:<br>The Committee considered the case as per agenda and it was decided to fix ad-hoc norms under Para 4.07<br>of HBP Vol. I as per details given below or as applied by the firm, whichever is less:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>Iohexol 300 mg I/ml Solution for Injection<br>647 mg/300 mg I/50 ml Vial<br>38321 Vials<br>1<br>Iohexol<br>1301.66 kg.<br>Iohexol 350 mg I/ml Solution for Injection<br>755 mg /350 mg I/50 ml Vial<br>32839 Vials<br>2<br>Iohexol<br>1301.66 kg.<br>RA concerned may take further necessary action as per above decision of NC.

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

cessary action as per above decision of NC.||

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

Case No.	15 / NC/3/MEET/Jan/202526/12
Case Status	Case Deferred
Party Name	KEVA FRAGRANCES PRIVATE LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM REVIW00001411AM25
RA File Number	039404000052 AM20
Licence No and<br>Date	0310828561/24/04/2019
Norms Committee Decision:<br>The Committee considered the case as per the agenda and observed that the nature of the export item, i.e.,<br>FLAVOURING ESSENCES , has not been clearly specified in the documents submitted, particularly<br>whether it is intended for use as a perfumery item or as a flavouring agent, which is required for<br>compliance with the provisions(list of ineligible item under self-declaration basis) of Para 4.11 of FTP<br>‑2023.After detailed deliberations and based on the recommendations of the Technical Authority, the<br>Committee decided to direct the firm to furnish the following information:<br>(i) End use of export item supporting by technical documents

the recommendations of the Technical Authority, the Committee decided to direct the firm to furnish the following information: (i) End use of export item supporting by technical documents||

Case No.	16 / NC/3/MEET/Jan/202526/12
Case Status	Case Deferred
Party Name	KEVA FRAGRANCES PRIVATE LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM REVIW00001456AM25
RA File Number	039404000462 AM20
Licence No and<br>Date	0310831524/13/09/2019
Norms Committee Decision:<br>The Committee considered the case as per the agenda and observed that the nature of the export item, i.e.,<br>FLAVOURING ESSENCES , has not been clearly specified in the documents submitted, particularly<br>whether it is intended for use as a perfumery item or as a flavouring agent, which is required for<br>compliance with the provisions(list of ineligible item under self-declaration basis) of Para 4.11 of FTP

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

‑2023. After detailed deliberations and based on the recommendations of the Technical Authority, the Committee decided to direct the firm to furnish the following information:

(i) End use of export item supporting by technical documents

ased on the recommendations of the Technical Authority, the Committee decided to direct the firm to furnish the following information:

(i) End use of export item supporting by technical documents

Case No.	17 / NC/3/MEET/Jan/202526/12
Case Status	Case Deferred
Party Name	KEVA FRAGRANCES PRIVATE LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM REVIW00001452AM25
RA File Number	039404000218 AM21
Licence No and<br>Date	0310837120/09/07/2020
Norms Committee Decision:<br>The Committee considered the case as per the agenda and observed that the nature of the export item, i.e.,<br>FLAVOURING ESSENCES , has not been clearly specified in the documents submitted, particularly<br>whether it is intended for use as a perfumery item or as a flavouring agent, which is required for<br>compliance with the provisions(list of ineligible item under self-declaration basis) of Para 4.11 of FTP<br>‑2023.After detailed deliberations and based on the recommendations of the Technical Authority, the<br>Committee decided to direct the firm to furnish the following information:<br>(i) End use of export item supporting by technical documents

Case No.	18 / NC/3/MEET/Jan/202526/12
Case Status	Case Rejected
Party Name	ACUTAAS CHEMICALS LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM REVIW00005112AM25
RA File Number	52AA04010429 AM22
Licence No and<br>Date	5211001058/27/07/2021
Norms Committee Decision:

3/ MEET/ Jan/ 202526/ 12 and 15/01/2026| |HQ File Number|HQRNORM REVIW00005112AM25| |RA File Number|52AA04010429 AM22| |Licence No and Date|5211001058/27/07/2021| |Norms Committee Decision:||

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

The Committee considered the firm’s request for review of the ad-hoc norms. However, it was observed that the firm had not furnished any technical justification or supporting information for the proposed enhancement. Accordingly, the Committee did not find any merit in the request and decided to reject the case, thereby maintaining the status quo.

Case No.	19 / NC/3/MEET/Jan/202526/12
Case Status	Case Approved
Party Name	RUMIT LIFE CARE
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM REVIW00004885AM25
RA File Number	03AX04001057 AM23
Licence No and<br>Date	0311015409/10/06/2022
Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,whichever is less, as per the details indicated below.:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>Diflucortolone Valerate BP<br>1 kg.<br>1<br>Flumethasone<br>0.925 kg.<br>RA concerned may take further necessary action as per above decision of NC.

r>Sl. No. Import Items Qty. allowed. Diflucortolone Valerate BP 1 kg. 1 Flumethasone 0.925 kg. RA concerned may take further necessary action as per above decision of NC.||

Case No.	20 / NC/3/MEET/Jan/202526/12
Case Status	Case Deferred
Party Name	KEVA FRAGRANCES PRIVATE LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM REVIW00001455AM25
RA File Number	03AX04002522 AM23
Licence No and	0311017151/12/08/2022

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

Date

Norms Committee Decision:

‑2023. After detailed deliberations and based on the recommendations of the Technical Authority, the Committee decided to direct the firm to furnish the following information:

(i) End use of export item supporting by technical documents

Case No.	21 / NC/3/MEET/Jan/202526/12
Case Status	Case Rejected
Party Name	ASSOCIATED DYESTUFF PRIVATE LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM REVIW00001845AM25
RA File Number	08AX04001207 AM23
Licence No and<br>Date	0811006504/22/11/2022
Norms Committee Decision:<br>The Committee considered the case as per the agenda and noted that the firm has failed to furnish a reply to<br>the deficiency letter despite repeated reminders and adequate opportunities being provided. In the absence<br>of the required information and documents, the Committee decided to reject the case.

the deficiency letter despite repeated reminders and adequate opportunities being provided. In the absence of the required information and documents, the Committee decided to reject the case.||

Case No.	22 / NC/3/MEET/Jan/202526/12
Case Status	Case Deferred
Party Name	JUBILANT INGREVIA LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00005825AM23
RA File Number	05AX04003069 AM23
Licence No and<br>Date	0511016941/19/01/2023
Norms Committee Decision:

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

As per the advice of the technical authority, the firm was asked to attend a personal hearing through video conference to explain its case. However, the personal hearing could not be conducted due to technical issues beyond control. In view of this, the Committee decided to provide another opportunity to the firm by conducting the personal hearing through video conference in the ensuing meeting.

echnical issues beyond control. In view of this, the Committee decided to provide another opportunity to the firm by conducting the personal hearing through video conference in the ensuing meeting.

Case No.	23 / NC/3/MEET/Jan/202526/12
Case Status	Case Deferred
Party Name	SYNERGIA SCIENCES PRIVATE LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00006312AM23
RA File Number	03AX04005369 AM23
Licence No and<br>Date	0311021429/14/02/2023
Norms Committee Decision:<br>As per the advice of the technical authority, the firm was asked to attend a personal hearing through video<br>conference to explain its case. However, the personal hearing could not be conducted due to technical issues<br>beyond control. In view of this, the Committee decided to provide another opportunity to the firm by<br>conducting the personal hearing through video conference in the ensuing meeting.

issues beyond control. In view of this, the Committee decided to provide another opportunity to the firm by conducting the personal hearing through video conference in the ensuing meeting.||

Case No.	24 / NC/3/MEET/Jan/202526/12
Case Status	Case Approved
Party Name	NAVIN FLUORINE ADVANCED SCIENCES LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM REVIW00006354AM25
RA File Number	03AX04006341 AM23
Licence No and<br>Date	0311022753/12/04/2023
Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,whichever is less, as per the details indicated below.:-

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>1<br>Acetaldoxime<br>2.01 kg.<br>3<br>Trifluoro<br>Methyl<br>Acetophenone<br>1 kg.<br>2<br>Meta Amino Benzotrifluoride<br>1.96 kg.<br>RA concerned may take further necessary action as per above decision of NC.	Export Product	Qty.	Sl. No.	Import Items	Qty. allowed.
	3<br>Trifluoro<br>Methyl<br>Acetophenone	<br>1 kg.	1	Acetaldoxime	2.01 kg.
			2	Meta Amino Benzotrifluoride	1.96 kg.

roduct|Qty.|Sl. No.|Import Items|Qty. allowed.| |---|---|---|---|---|---| ||3 Trifluoro Methyl Acetophenone| 1 kg.|1|Acetaldoxime|2.01 kg.| ||||2|Meta Amino Benzotrifluoride|1.96 kg.|

Case No.	25 / NC/3/MEET/Jan/202526/12
Case Status	Case Deferred
Party Name	AGRO SOLVENT PRODUCTS PVT LTD
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00001107AM24
RA File Number	56AX04000449 AM23
Licence No and<br>Date	5611001909/25/05/2023
Norms Committee Decision:<br>As per the advice of the technical authority, the firm was asked to attend a personal hearing through video<br>conference to explain its case. However, the personal hearing could not be conducted due to technical issues<br>beyond control. In view of this, the Committee decided to provide another opportunity to the firm by<br>conducting the personal hearing through video conference in the ensuing meeting.

Case No.	26 / NC/3/MEET/Jan/202526/12
Case Status	Case Deferred
Party Name	FRESENIUS KABI INDIA PRIVATE LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00004957AM24
RA File Number	03AX04002106 AM24
Licence No and<br>Date	0311026174/09/08/2023
Norms Committee Decision:

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

6174/09/08/2023| |Norms Committee Decision:||

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

Case No.<br>27 / NC/3/MEET/Jan/202526/12
Case Status<br>Case Deferred
Party Name<br>FRESENIUS KABI INDIA PRIVATE LIMITED
Meeting Number<br>and Date<br>NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number<br>HQRNORM APPLY 00005822AM24
RA File Number<br>03AX04002768 AM24
Licence No and<br>Date<br>0311027333/22/09/2023
Norms Committee Decision:
As per the advice of the technical authority, the firm was asked to attend a personal hearing through video
conference to explain its case. However, the personal hearing could not be conducted due to technical issues
beyond control. In view of this, the Committee decided to provide another opportunity to the firm by
conducting the personal hearing through video conference in the ensuing meeting.

al issues| |beyond control. In view of this, the Committee decided to provide another opportunity to the firm by| |conducting the personal hearing through video conference in the ensuing meeting.|

Case No.	28 / NC/3/MEET/Jan/202526/12
Case Status	Case Approved
Party Name	MICRO LABS LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM REVIW00004787AM25
RA File Number	07AX04001679 AM24
Licence No and<br>Date	0711010304/23/01/2024
Norms Committee Decision:
The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the
Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority
or as applied for	by the firm,whichever is less, as per the details indicated below.:-

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

ess**, as per the details indicated below.:-|

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

Export Product	Qty.	Sl. No.	Import Items	Qty. allowed.
Lisinopril 2.5 mg Tablets (Each tablet<br>containing Lisinopril Dihydrate – eq. to<br>Lisinopril 2.5 mg)	<br> <br>1 Number	1	Lisinopril<br>Dihydrate<br>BP/EP/IP/USP	<br>2.777 mg.
Lisinopril 5 mg Tablets (Each tablet<br>containing Lisinopril Dihydrate – eq. to<br>Lisinopril 5 mg)	<br> <br>1 Number	2	Lisinopril<br>Dihydrate<br>BP/EP/IP/USP	<br>5.553 mg.
Lisinopril 10 mg Tablets (Each tablet<br>containing Lisinopril Dihydrate – eq.

ril Dihydrate – eq. to Lisinopril 5 mg)| 1 Number|2|Lisinopril Dihydrate BP/EP/IP/USP| 5.553 mg.| ||Lisinopril 10 mg Tablets (Each tablet containing Lisinopril Dihydrate – eq. to Lisinopril 10 mg)| 1 Number|3|Lisinopril Dihydrate BP/EP/IP/USP| 11.106 mg.| ||Lisinopril 20 mg Tablets (Each tablet containing Lisinopril Dihydrate – eq. to Lisinopril 20 mg)| 1 Number|4|Lisinopril Dihydrate BP/EP/IP/USP| 22.212 mg.|

Case No.	29 / NC/3/MEET/Jan/202526/12
Case Status	Case Deferred
Party Name	JUBILANT INGREVIA LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00008210AM24
RA File Number	05AX04003445 AM24
Licence No and<br>Date	0511023507/30/01/2024
Norms Committee Decision:<br>As per the advice of the technical authority, the firm was asked to attend a personal hearing through video<br>conference to explain its case. However, the personal hearing could not be conducted due to technical issues<br>beyond control. In view of this, the Committee decided to provide another opportunity to the firm by<br>conducting the personal hearing through video conference in the ensuing meeting.

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

gh video conference in the ensuing meeting.||

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

Case No.	30 / NC/3/MEET/Jan/202526/12
Case Status	Case Deferred
Party Name	FRESENIUS KABI INDIA PRIVATE LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00009103AM24
RA File Number	03AX04005671 AM24
Licence No and<br>Date	0311032149/14/03/2024
Norms Committee Decision:<br>As per the advice of the technical authority, the firm was asked to attend a personal hearing through video<br>conference to explain its case. However, the personal hearing could not be conducted due to technical issues<br>beyond control. In view of this, the Committee decided to provide another opportunity to the firm by<br>conducting the personal hearing through video conference in the ensuing meeting.

issues beyond control. In view of this, the Committee decided to provide another opportunity to the firm by conducting the personal hearing through video conference in the ensuing meeting.||

Case No.<br>	31 / NC/3/MEET/Jan/202526/12
Case Status<br>	Case Approved
Party Name<br>	AGGARWWAL EXPORTS
Meeting Number<br>and Date<br>	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number<br>	HQRNORM APPLY 00001484AM25
RA File Number<br>	05AX04000858 AM25
Licence No and<br>Date<br>	0511026193/21/06/2024
Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,whichever is less, as per the details indicated below.:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>L-carnitine L-tartrate<br>1 kg.<br>1<br>(3R)-3-Hydroxy-4-(Trimethylammonio)<br>Butanoic Acid Inner Salt )<br>0.696 kg.<br>RA concerned may take further necessary action as per above decision of NC.

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

cessary action as per above decision of NC.||

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

Case No.	32 / NC/3/MEET/Jan/202526/12
Case Status	Case Approved
Party Name	RUBICON RESEARCH LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00001762AM25
RA File Number	03AX04001633 AM25
Licence No and<br>Date	0311035236/05/07/2024
Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,whichever is less, as per the details indicated below.:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>1<br>Primidone USP<br>250.0 mg.<br>Primidone Tab 250 mg (Net content<br>of Primidone API. is 1925.25 kg and<br>of Lactose monohydrate NF is<br>616.35 kg)<br>1 Number<br>2<br>Lactose monohydrate NF<br>80.035 mg.<br>3<br>Primidone USP<br>50.00 mg.<br>Primidone Tab 50 mg (Net content<br>of Primidone API. is 3220.10 kg and<br>of Lactose monohydrate NF is<br>1088.84 kg)<br>1 Number<br>4<br>Lactose monohydrate NF<br>16.907 mg.<br>RA concerned may take further necessary action as per above decision of NC.

0.10 kg and of Lactose monohydrate NF is 1088.84 kg) 1 Number 4 Lactose monohydrate NF 16.907 mg. RA concerned may take further necessary action as per above decision of NC.||

Case No.	33 / NC/3/MEET/Jan/202526/12
Case Status	Case Approved
Party Name	COHANCE LIFESCIENCES LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

HQ File Number	HQRNORM APPLY 00001770AM25
RA File Number	09AX04000214 AM25
Licence No and<br>Date	0911007551/05/07/2024
Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,whichever is less, as per the details indicated below.:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>Posaconazole Delayed Release<br>Tablets 100 mg<br>1 Number<br>1<br>Posaconazole Premix<br>(Posaconazole 28.57 % &<br>Hypromellose Acetate<br>Succinate 71.43 %<br>Posaconazole Premix 100 mg Each<br>350 mg Premix Contains 100 mg<br>of Posaconazole)<br>351.75 mg<br>RA concerned may take further necessary action as per above decision of NC.

cinate 71.43 % Posaconazole Premix 100 mg Each 350 mg Premix Contains 100 mg of Posaconazole) 351.75 mg RA concerned may take further necessary action as per above decision of NC.||

Case No.	34 / NC/3/MEET/Jan/202526/12
Case Status	Case Rejected
Party Name	CHROMO LABORATORIES INDIA PRIVATE LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00002535AM25
RA File Number	09AX04000325 AM25
Licence No and<br>Date	0911007740/14/08/2024
Norms Committee Decision:<br>The Committee considered the case as per the agenda and noted that the firm has failed to furnish a reply to<br>the deficiency letter despite repeated reminders and adequate opportunities being provided. In the absence<br>of the required information and documents, the Committee decided to reject the case.

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

, the Committee decided to reject the case.||

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

Case No.	35 / NC/3/MEET/Jan/202526/12
Case Status	Case Approved
Party Name	LINCOLN PHARMACEUTICALS LTD
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00002591AM25
RA File Number	08AX04000799 AM25
Licence No and<br>Date	0811012437/20/08/2024
Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,whichever is less, as per the details indicated below.:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>Leucovorin Calcium Tablets<br>USP 5 mg ((Total 449992.00<br>TAB x 6.70 mg = 3.01 kg. Net<br>Contain.) (As Calcium Folinate<br>Hydrate EP) will be as per<br>below formula = (5.4 X 100 X<br>100) / (97 X (100 -17)) = 54000<br>/ 8051 = 6.70 mg))<br>449992<br>Numbers<br>1<br>Calcium Folinate Hydrate EP<br>2.577 kg.<br>RA concerned may take further necessary action as per above decision of NC.

97 X (100 -17)) = 54000 / 8051 = 6.70 mg)) 449992 Numbers 1 Calcium Folinate Hydrate EP 2.577 kg. RA concerned may take further necessary action as per above decision of NC.||

Case No.	36 / NC/3/MEET/Jan/202526/12
Case Status	Case Approved
Party Name	SUN PHARMACEUTICAL INDUSTRIES LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00002625AM25
RA File Number	05AX04001393 AM25
Licence No and<br>Date	0511027293/21/08/2024

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

|Nor Th Co or|ms Committee Decision: e Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the mmittee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority as applied for by the firm,whichever is less, as per the details indicated below.:- Norms for 1 Number Tablet/Capsule: A.|ms Committee Decision: e Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the mmittee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority as applied for by the firm,whichever is less, as per the details indicated below.:- Norms for 1 Number Tablet/Capsule: A.|ms Committee Decision: e Committee examined the request of the firm for fixation of ad-hoc norms .

ever is less**, as per the details indicated below.:- Norms for 1 Number Tablet/Capsule: A.|ms Committee Decision: e Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the mmittee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority as applied for by the firm,whichever is less, as per the details indicated below.:- Norms for 1 Number Tablet/Capsule: A.| |---|---|---|---| ||Export Product|Qty. allowed.|| ||Entecavir Monohydrate|0.543 mg./0.5 mg Tablet/Cabsule|| ||Entecavir Monohydrate|1.086 mg./1 mg. Tablet/Capsule|| ||Norms for 1 kg. Entecavir Monohydrate: B.||| ||Import Item||Qty. allowed| ||Acetone||Not showing in Process/Flow Chart/Reactions.| ||Activated Carbon||0.193 kg.| ||Boron Trichloride 1M Sol In Meth.Chlorid||31.55 kg.| ||Caustic Soda Flakes||0.964 kg.| ||(2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-(benzyloxy)-3- (benzyloxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one)||1.928 kg.| ||Hydrochloric Acid LR||0.964 kg.| ||Hyflosupercel||0.578 kg.| ||Methanol||14.50 kg.|

Norms Committee Decision:

The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority or as applied for by the firm, whichever is less , as per the details indicated below.:-

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

Methylene Chloride 15.75 kg.

Case No.	37 / NC/3/MEET/Jan/202526/12
Case Status	Case Rejected
Party Name	MANGALAM DRUGS AND ORGANICS LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00002694AM25
RA File Number	03AX04002297 AM25
Licence No and<br>Date	0311036650/26/08/2024
Norms Committee Decision:<br>The Committee considered the case as per the agenda and noted that the firm has failed to furnish a reply to<br>the deficiency letter despite repeated reminders and adequate opportunities being provided. In the absence<br>of the required information and documents, the Committee decided to reject the case.

the deficiency letter despite repeated reminders and adequate opportunities being provided. In the absence of the required information and documents, the Committee decided to reject the case.||

Case No.	38 / NC/3/MEET/Jan/202526/12
Case Status	Case Rejected
Party Name	KRUNAL INDUSTRIES PRIVATE LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00003168AM25
RA File Number	08AX04000983 AM25
Licence No and<br>Date	0811012687/19/09/2024
Norms Committee Decision:<br> The Committee considered the case as per the agenda and noted that the firm has failed to furnish a reply to<br>the deficiency letter despite repeated reminders and adequate opportunities being provided. In the absence<br>of the required information and documents, the Committee decided to reject the case.

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

, the Committee decided to reject the case.||

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

Case No.	39 / NC/3/MEET/Jan/202526/12
Case Status	Case Deferred
Party Name	NIXI LABORATORIES PRIVATE LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00003472AM25
RA File Number	03AX04003192 AM25
Licence No and<br>Date	0311037637/04/10/2024
Norms Committee Decision:<br>The Committee considered the case as per agenda and it was observed that the firm still has not furnished<br>the reply of deficiency letter. Hence, the Committee decided to grant one final opportunity to the firm to<br>submit the requisite documents for further consideration of the case.

Case No.	Case No.	40 / NC/3/MEET/Jan/202526/12	40 / NC/3/MEET/Jan/202526/12	40 / NC/3/MEET/Jan/202526/12	40 / NC/3/MEET/Jan/202526/12	40 / NC/3/MEET/Jan/202526/12
Case Status		Case Approved
Party Name		SV PLASTOCHEM PRIVATE LIMITED
Meeting Number<br>and Date		NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number		HQRNORM APPLY 00003682AM25
RA File Number		31AX04000348 AM24
Licence No and<br>Date		3111003982/16/10/2024
Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms .

|RA File Number||31AX04000348 AM24||||| |Licence No and Date||3111003982/16/10/2024||||| |Norms Committee Decision: The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority or as applied for by the firm,whichever is less, as per the details indicated below.:- Export Product Qty. Sl. No. Import Items Qty. allowed. 1 TIN INGOTS 0.497 kg. SV CAT 2000 (MONO BUTYL TIN OXIDE POWDER 98 %) 1 kg. 2 TETRA BUTYL TIN TBT 0.441 kg.||||||| ||Export Product||Qty.|Sl. No.|Import Items|Qty. allowed.| ||SV CAT 2000 (MONO BUTYL TIN OXIDE POWDER 98 %)||1 kg.|1|TIN INGOTS|0.497 kg.| |||||2|TETRA BUTYL TIN TBT|0.441 kg.| ||||||||

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

|||2|TETRA BUTYL TIN TBT|0.441 kg.| ||||||||

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

Case No.	41 / NC/3/MEET/Jan/202526/12
Case Status	Case Approved
Party Name	SV PLASTOCHEM PRIVATE LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00003691AM25
RA File Number	31AX04000043 AM22
Licence No and<br>Date	3111003987/17/10/2024
Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,whichever is less, as per the details indicated below.:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>1<br>Tin Ingots<br>0.126 kg.<br>2<br>Tetra Butyl Tin TBT<br>0.28 kg.<br>Di Butyl Tin Dilaurate (DBTDL)<br>1 kg.<br>3<br>Lauric Acid<br>0.65 kg<br>RA concerned may take further necessary action as per above decision of NC.

Case No.	42 / NC/3/MEET/Jan/202526/12
Case Status	Case Approved
Party Name	ACUTAAS CHEMICALS LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00003737AM25

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

| |HQ File Number|HQRNORM APPLY 00003737AM25|

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

RA File Number

52AX04000217 AM25

Licence No and Date

5211010354/18/10/2024

Norms Committee Decision: The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority or as applied for by the firm,whichever is less, as per the details indicated below.:- Export Product Qty. Sl. No. Import Items Qty. allowed. 1 1-(2-Tetrahydropyranyl)-1H Pyrazole-5-Boronic Acid Pinacol Ester ( 1-(Tetrahydro 2H Pyran 2yl) -5-(4,4,5,5 Tetramethyl 1,3,2 Dioxaborolane-2-yl)-1H- Pyrazole) ) 1.50 kg. 2 4-Bromo-2-Chloro Benzonitrile 1.165 kg. 3 L-Alininol)) (2-Amino-1- Propanol (S- (+) - 2-Amino-1- Propanol) ((S)-2-aminopropan- 1-ol (L-Alininol) 0.46 kg. 4 Di Tert Butyl Dicarbonate 1.34 kg. Heterocyclic Compounds With Nitrogen Atom With An Unfused Pyrazole Ring With Hydrogenated In The Structure: 4-{1-[(2S)-(Heterocyclic Compounds With Nitrogen Atom With An Unfused Pyrazole Ring With Hydrogenated In The Structure: 4-{1-[(2S)-2-Aminopropyl]-1-H- Pyrazole-3-yl}-2- Chlorobenzonitrile ) 1 kg. 5 Di-isopropyl azodicarboxylate 1.034 kg. RA concerned may take further necessary action as per above decision of NC.

nopropyl]-1-H- Pyrazole-3-yl}-2- Chlorobenzonitrile ) 1 kg. 5 Di-isopropyl azodicarboxylate 1.034 kg. RA concerned may take further necessary action as per above decision of NC.||

Case No.	43 / NC/3/MEET/Jan/202526/12
Case Status	Case Deferred
Party Name	BHAGWATI ORGANICS PRIVATE LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

HQ File Number	HQRNORM APPLY 00003824AM25
RA File Number	08AX04001178 AM25
Licence No and<br>Date	0811012998/23/10/2024
Norms Committee Decision:<br>The Committee considered the case as per agenda and it was observed that the firm still has not furnished<br>the reply of deficiency letter. Hence, the Committee decided to grant one final opportunity to the firm to<br>submit the requisite documents for further consideration of the case.

furnished the reply of deficiency letter. Hence, the Committee decided to grant one final opportunity to the firm to submit the requisite documents for further consideration of the case.||

Case No.	Case No.	44 / NC/3/MEET/Jan/202526/12	44 / NC/3/MEET/Jan/202526/12	44 / NC/3/MEET/Jan/202526/12	44 / NC/3/MEET/Jan/202526/12	44 / NC/3/MEET/Jan/202526/12
Case Status		Case Approved
Party Name		RUBICON RESEARCH LIMITED
Meeting Number<br>and Date		NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number		HQRNORM APPLY 00003973AM25
RA File Number		03AX04003873 AM25
Licence No and<br>Date		0311038428/04/11/2024
Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms. After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,whichever is less, as per the details indicated below.:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>1<br>Cevimeline USP<br>30.0 mg<br>Cevimeline HCI Cap 30 mg (Net<br>content of Cevimeline API. is<br>105.00 kg and of Lactose<br>Monohydrate NF is 441 kg))<br>1 Number<br>2<br>Lactose Monohydrate NF<br>126.0 mg.<br>3<br>Dicyclomine USP<br>20.0 mg.<br>Dicyclomine HCI Tab USP<br>20mg (Net content of Baclofen<br>API.

f Lactose Monohydrate NF is 441 kg)) 1 Number 2 Lactose Monohydrate NF 126.0 mg. 3 Dicyclomine USP 20.0 mg. Dicyclomine HCI Tab USP 20mg (Net content of Baclofen API. is 3786.80 kg and of Lactose Monohydrate NF is 24689.94 kg)) 1 Number 4 Lactose Monohydrate NF 130.4 mg. RA concerned may take further necessary action as per above decision of NC.||||||| ||Export Product||Qty.|Sl. No.|Import Items|Qty. allowed.| ||Cevimeline HCI Cap 30 mg (Net content of Cevimeline API. is 105.00 kg and of Lactose Monohydrate NF is 441 kg))|| 1 Number|1|Cevimeline USP|30.0 mg| |||||2|Lactose Monohydrate NF|126.0 mg.| ||Dicyclomine HCI Tab USP 20mg (Net content of Baclofen API. is 3786.80 kg and of Lactose Monohydrate NF is 24689.94 kg))||1 Number|3|Dicyclomine USP|20.0 mg.| |||||4|Lactose Monohydrate NF|130.4 mg.| |||||per above decision of NC.|||

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

|130.4 mg.| |||||per above decision of NC.|||

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

Case No.	45 / NC/3/MEET/Jan/202526/12
Case Status	Case Approved
Party Name	MANGALAM ORGANICS LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00004063AM25
RA File Number	03AX04002657 AM25
Licence No and<br>Date	0311038605/11/11/2024
Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,whichever is less, as per the details indicated below.:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>1<br>Acetic Acid<br>0.464 kg.<br>Sodium Acetate (Trihydrate)<br>1 kg.<br>2<br>Caustic Soda<br>0.309 kg.<br>RA concerned may take further necessary action as per above decision of NC.

Case No.	46 / NC/3/MEET/Jan/202526/12
Case Status	Case Deferred
Party Name	ARESKO LIFE SCIENCES PRIVATE LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00004065AM25
RA File Number	05AX04002537 AM25
Licence No and<br>Date	0511028833/11/11/2024
Norms Committee Decision:

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

ce No and Date|0511028833/11/11/2024| |Norms Committee Decision:||

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

The Committee considered the case as per agenda and it was observed that the firm still has not furnished the reply of deficiency letter. Hence, the Committee decided to grant one final opportunity to the firm to submit the requisite documents for further consideration of the case.

Case No.	47 / NC/3/MEET/Jan/202526/12
Case Status	Case Deferred
Party Name	SYNERGIA SCIENCES PRIVATE LIMITED
Meeting Number<br>and Date	NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number	HQRNORM APPLY 00004086AM25
RA File Number	03AX04003672 AM25
Licence No and<br>Date	0311038648/12/11/2024
Norms Committee Decision:<br>As per the advice of the technical authority, the firm was asked to attend a personal hearing through video<br>conference to explain its case. However, the personal hearing could not be conducted due to technical issues<br>beyond control. In view of this, the Committee decided to provide another opportunity to the firm by<br>conducting the personal hearing through video conference in the ensuing meeting.

ssues beyond control. In view of this, the Committee decided to provide another opportunity to the firm by conducting the personal hearing through video conference in the ensuing meeting.||

Case No.	Case No.	48 / NC/3/MEET/Jan/202526/12	48 / NC/3/MEET/Jan/202526/12	48 / NC/3/MEET/Jan/202526/12	48 / NC/3/MEET/Jan/202526/12	48 / NC/3/MEET/Jan/202526/12
Case Status		Case Approved
Party Name		STERMONE CHEMICALS PRIVATE LIMITED
Meeting Number<br>and Date		NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026
HQ File Number		HQRNORM APPLY 00004192AM25
RA File Number		34AX04000685 AM25
Licence No and<br>Date		3411005667/18/11/2024
Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,whichever is less, as per the details indicated below.:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.
	Export Product		Qty.	Sl. No.	Import Items	Qty. allowed.

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

Diflucortolone Valerate BP/JP 1 kg. 1 Flumethasone 0.925 kg.

==> picture [483 x 237] intentionally omitted <==

07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26

Diflucortolone Valerate BP/JP 1 kg. 1 Flumethasone 0.925 kg.

==> picture [483 x 237] intentionally omitted <==

----- Start of picture text -----

|||
|---|---|
|Case No.|49 / NC/3/MEET/Jan/202526/12|
|Case Status|Case Deferred|
|Party Name|SUN PHARMACEUTICAL INDUSTRIES LIMITED|
|Meeting Number|
|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|and Date|
|HQ File Number|HQRNORM APPLY 00004214AM25|
|RA File Number|05AX04002700 AM25|
|Licence No and|
|0511029003/19/11/2024|
|Date|
|Norms Committee Decision:|
|The Committee considered the case as per the agenda and observed that the reply furnished by the firm to|
|the deficiency letter is not convincing, as the export item is a 5 ml vial, whereas the corresponding import|
|item is 1 litre Polyelite EL powder. In view of the mismatch and the issues involved, the Committee decided|
|to call the firm for a personal hearing before the Norms Committee to explain its case, along with|
|submission of a sample of import item No. 2.|

----- End of picture text -----

==> picture [483 x 244] intentionally omitted <==

e Norms Committee to explain its case, along with| |submission of a sample of import item No. 2.|


**----- End of picture text -----**<br>


**==> picture [483 x 244] intentionally omitted <==**

**----- Start of picture text -----**<br>
```text
||||||
|---|---|---|---|---|
|Case No.|50 / NC/3/MEET/Jan/202526/12|
|Case Status|Case Approved|
|Party Name|VENUS REMEDIES LIMITED|
|Meeting Number|
|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|and Date|
|HQ File Number|HQRNORM APPLY 00004262AM25|
|RA File Number|30AX04000446 AM25|
|Licence No and|
|3011006063/21/11/2024|
|Date|
|Norms Committee Decision:|
|The Committee examined the request of the firm for fixation of ad-hoc norms. After due deliberation, the|
|Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority|
|or as applied for by the firm,|whichever is less|, as per the details indicated below.:-|
|Export Product|Qty.|Sl. No.|Import Items|Qty. allowed.|

----- End of picture text -----

Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

UDIN00566232AM26


**----- End of picture text -----**<br>



Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


33 

UDIN00566232AM26 

|Docetaxel Injection Concentrate (20|1 Number|1|Docetaxel Trihydrate|23.468 mg.|
|---|---|---|---|---|
|mg / 0.5 ml) (Each 0.5 ml Contains:|||||
|Docetaxel Trihydrate Eqv. To|||||
|Anhydrous Docetaxel...20 mg,|||||
|Polysorbate-80 USP...Q.S. Containing|||||
|990.040 gm of|||||
|Docetaxel Trihydrate)|||||
|Docetaxel Injection Concentrate (80|1 Number|2|Docetaxel Trihydrate|93.873 mg.|
|mg /2.0 ml) (Each 0.5 Ml Contains:|||||
|Docetaxel Trihydrate Eqv. To|||||
|Anhydrous Docetaxel...20 mg,|||||
|Polysorbate-80 USP...Q.S Containing|||||
|2650.039 gm of Docetaxel Trihydrate)|||||
|Docetaxel Injection Concentrate (120|1 Number|3|Docetaxel Trihydrate|140.81 mg.|
|mg /3.0 Ml) (Each 0.5 Ml Contains:|||||
|Docetaxel Trihydrate Eqv. To|||||
|Anhydrous Docetaxel...20 mg,|||||
|Polysorbate-80 USP...Q.S Containing|||||
|3360 gm of Docetaxel Trihydrate)|||||

g.|
|mg /3.0 Ml) (Each 0.5 Ml Contains:|||||
|Docetaxel Trihydrate Eqv. To|||||
|Anhydrous Docetaxel...20 mg,|||||
|Polysorbate-80 USP...Q.S Containing|||||
|3360 gm of Docetaxel Trihydrate)|||||




|Case No.|51 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|BVC SPECIALITIES PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00004278AM25|
|RA File Number|34AX04000703 AM25|
|Licence No and<br>Date|3411005691/21/11/2024|
|Norms Committee Decision:||
|The Committee considered the case as per the agenda and observed that the nature of the export item, i.e.,||
|FLAVOURING|ESSENCES , has not been clearly specified in the documents submitted, particularly|
|whether it is intended for use as a perfumery item or as a flavouring agent, which is required for||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


34 

UDIN00566232AM26 

compliance with the provisions(list of ineligible item under self-declaration basis) of Para 4.11 of FTP 

‑2023. After detailed deliberations and based on the recommendations of the Technical Authority, the Committee decided to direct the firm to furnish the following information: 

(i)  End use of export item supporting by technical documents

sed on the recommendations of the Technical Authority, the Committee decided to direct the firm to furnish the following information: 

(i)  End use of export item supporting by technical documents 

|Case No.|52 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|BVC SPECIALITIES PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00004279AM25|
|RA File Number|34AX04000704 AM25|
|Licence No and<br>Date|3411005693/21/11/2024|
|Norms Committee Decision:<br>The Committee considered the case as per the agenda and observed that the nature of the export item, i.e.,<br>FLAVOURING ESSENCES , has not been clearly specified in the documents submitted, particularly<br>whether it is intended for use as a perfumery item or as a flavouring agent, which is required for<br>compliance with the provisions(list of ineligible item under self-declaration basis) of Para 4.11 of FTP<br>‑2023.After detailed deliberations and based on the recommendations of the Technical Authority, the<br>Committee decided to direct the firm to furnish the following information:<br>(i) End use of export item supporting by technical documents||



|Case No.|53 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|MAC-CHEM PRODUCTS (INDIA) PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00004291AM25|
|RA File Number|03AX04004099 AM25|
|Licence No and|0311038941/22/11/2024|

TED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00004291AM25|
|RA File Number|03AX04004099 AM25|
|Licence No and|0311038941/22/11/2024|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


35 

UDIN00566232AM26 

Date 

Norms Committee Decision: 

The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority or as applied for by the firm, **whichever is less** , as per the details indicated below.:- 

|Export Product|Qty.|Sl. No.|Import Items|Qty. allowed.|
|---|---|---|---|---|
|Acyclovir For Injection<br>( Lyophilised Sterile Bulk )|1 kg.|1|Acyclovir EP 11.5<br>(Non-Sterile)|0.911 kg.|




|Case No.|Case No.|54 / NC/3/MEET/Jan/202526/12|54 / NC/3/MEET/Jan/202526/12|54 / NC/3/MEET/Jan/202526/12|54 / NC/3/MEET/Jan/202526/12|54 / NC/3/MEET/Jan/202526/12|
|---|---|---|---|---|---|---|
|Case Status||Case Approved|||||
|Party Name||SRINI PHARMACEUTICALS PRIVATE LIMITED|||||
|Meeting Number and<br>Date||NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|||||
|HQ File Number||HQRNORM APPLY 00004342AM25|||||
|RA File Number||09AX04000768 AM25|||||
|Licence No and Date||0911008474/25/11/2024|||||
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms .

||
|RA File Number||09AX04000768 AM25|||||
|Licence No and Date||0911008474/25/11/2024|||||
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>1<br>7-Chloro-1,2,3,4-<br>tetrahydrobenzo[b]azepin-5-one<br>0.759 kg.<br>2<br>2-Methyl-4-Nitro Benzoic Acid<br>0.703 kg.<br>7-Chloro-1-[2-Methyl-4-[(2-<br>Methylbenzoyl)<br>Amino]Benzoyl]-5-Oxo-<br>2,3,4,5-Tetrahydro-1H-1-<br>Benzazepine (TOV40)<br>1 kg.<br>3<br>Ortho Toluic Acid / 2- Methyl<br>benzoic acid<br>0.406 kg.|||||||
||Export Product||Qty.|Sl. No.|Import Items|Qty. allowed.|
||7-Chloro-1-[2-Methyl-4-[(2-<br>Methylbenzoyl)<br>Amino]Benzoyl]-5-Oxo-<br>2,3,4,5-Tetrahydro-1H-1-<br>Benzazepine (TOV40)||1 kg.|1|7-Chloro-1,2,3,4-<br>tetrahydrobenzo[b]azepin-5-one|0.759 kg.|
|||||2|2-Methyl-4-Nitro Benzoic Acid|0.703 kg.|
|||||3|Ortho Toluic Acid / 2- Methyl<br>benzoic acid|0.406 kg.|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


36 

UDIN00566232AM26

Acid / 2- Methyl<br>benzoic acid|0.406 kg.|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


36 

UDIN00566232AM26 


|Case No.|55 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Rejected|
|Party Name|HARMONY ORGANICS PVT LTD|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00004392AM25|
|RA File Number|31AX04000298 AM25|
|Licence No and<br>Date|3111004132/28/11/2024|
|Norms Committee Decision:||
|The firm was initially granted an Advance Authorisation for the export product_“_HEXYL SALICYLATE||
|_”_under Para 4.07 of the Handbook of Procedures (HBP). However, as per Para 4.11(b) of the Foreign||
|Trade Policy (FTP) 2023, products falling under the category of perfume or perfumery compounds are||
|ineligible for authorisation under Para 4.07 and are mandatorily required to be processed under Para 4.06||
|of the HBP.||
|It was observed that the firm obtained the authorisation by**misdeclaring that its application was**||
|**covered under the provisions of Para 4.07**, and has not furnished any technical justification/information||
|for the export product. Accordingly, the Committee found no merit in fixing the norms and decided to||
|reject the application.||
|The RA shall ensure that the said authorisation is regularised by recovery of applicable Customs duty||
|along with interest.

no merit in fixing the norms and decided to||
|reject the application.||
|The RA shall ensure that the said authorisation is regularised by recovery of applicable Customs duty||
|along with interest. Further, the RA should also submit a report on how this authorisation was issued||
|under Para 4.07 of HBP, to the Chairperson of the Norms Committee and to PC-4 Section, DGFT||
|Headquarters.||
|The RA concerned may take further necessary action in line with the above decision of the Committee.||



|Case No.|56 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|ALEMBIC PHARMACEUTICALS LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00004530AM25|
|RA File Number|34AX04000751 AM25|
|Licence No and<br>Date|3411005757/04/12/2024|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


37 

UDIN00566232AM26

## Norms Committee Decision: 

The committee considered the case as per the agenda and   after examination, it was observed that the firm has not furnished the requisite technical details as prescribed in Annexture to Appendix 4E. After detailed deliberations and in view of the recommendations of the Technical Authority, the Committee decided to ask the firm to furnish the following documents:

## (i) Copy of Master Batch Formula for each export item. 

|Nor<br>Th<br>fur<br>vie<br>fol<br>(i)|Nor<br>Th<br>fur<br>vie<br>fol<br>(i)|ms Committee Decision:<br>e committee considered the case as per t<br>nished the requisite technical details as pr<br>|ms Committee Decision:<br>e committee considered the case as per t<br>nished the requisite technical details as pr<br>|ms Committee Decision:<br>e committee considered the case as per t<br>nished the requisite technical details as pr<br>|he agenda and<br>escribed in Ann<br>|he agenda and<br>escribed in Ann<br>|after e<br>exture t<br>|after e<br>exture t<br>|xamination, it was observed that<br>o Appendix 4E. After detailed de<br>|xamination, it was observed that<br>o Appendix 4E. After detailed de<br>|xamination, it was observed that<br>o Appendix 4E. After detailed de<br>|the firm has not<br>liberations and in<br>|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||w of the recommendations of the Tech<br>lowing documents:<br>Copy of Master Batch Formula for e|||nical Authority<br>ach export ite||, the C<br>m.||ommittee decided to ask the fir|||m to furnish the|
||||||||||||||
||||||||||||||
|Cas||e No.|57 / NC/3/MEET/Jan/202||526/12||||||||
|Cas||e Status|Case Approved||||||||||
|Par||ty Name|STYRAX LIFE SCIENC||ES PRIVATE L||IMITED||||||
|Me<br>and||eting Number<br>Date|NC/ 3/ MEET/ Jan/ 20252||6/ 12 and 15/01||/2026||||||
|HQ File Number|||HQRNORM APPLY 00004588AM25||||||||||
|RA File Number|||09AX04000820 AM25||||||||||
|Licence No and<br>Date|||0911008546/06/12/2024||||||||||

Jan/ 20252||6/ 12 and 15/01||/2026||||||
|HQ File Number|||HQRNORM APPLY 00004588AM25||||||||||
|RA File Number|||09AX04000820 AM25||||||||||
|Licence No and<br>Date|||0911008546/06/12/2024||||||||||
|Norms Committee Decision:|||||||||||||
|The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:|||||||||||||
|||Exort Pr|duct||Qt|Sl No||Imort Items|||Qt allowed||
|||p|||y.|. .||p|||y. .||
||||||||||||||
|||1(4-Amino-5<br>(Hydroxyme|-Fluoro-1-[(2R,5S)-2-<br>nthyl)-1,2-Oxathiolan-||1 kg.|1||Glyoxalic Acid 50 PCT|||0.68 kg.||
||||||||||||||
|||5-YL] Pyrim|idin-2 (1H)-One or|||2||25-Dihydroxy-1 4-Diathine|||028 kg||
|||Emo-1)||||||,,|||. .||
|||||||3||5-Fluoro Cytosine|||0.44 kg.||
||||||||||||||
|||||||4||Sodium Borohydride|||0.28 kg.||
|||||||5||Hexa Methyl Disilazane|||0.53 kg.||
|||||||6|||||||
|||||||||Meth||ylene Di Chloride (MDC)|3.00 kg.||
|||||||7||||l Alhl A|1 k||
|||||||||Iso Pr||opy coo (IP))|.00 g.||
||||||||||||||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


38 

UDIN00566232AM26

so Pr||opy coo (IP))|.00 g.||
||||||||||||||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


38 

UDIN00566232AM26 


|Case No.|58 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|SALVI CHEMICAL INDUSTRIES LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00004591AM25|
|RA File Number|03AX04004397 AM25|
|Licence No and<br>Date|0311039396/06/12/2024|
|Norms Committee Decision:<br>The committee considered the case as per the agenda and   after examination, it was observed that the firm has not<br>furnished the requisite technical details as prescribed in  Annexture to Appendix 4E. After detailed deliberations and in<br>view of the recommendations of the Technical Authority, the Committee decided to ask the firm to furnish the<br>following documents:<br>(i) Complete chemistry with stoichiometric balance on molar basis with molecular weight of export and<br>import item and percentage of yield of the reaction.||

rnish the<br>following documents:<br>(i) Complete chemistry with stoichiometric balance on molar basis with molecular weight of export and<br>import item and percentage of yield of the reaction.||



|Case No.|59 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|SALVI CHEMICAL INDUSTRIES LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00004592AM25|
|RA File Number|03AX04004414 AM25|
|Licence No and<br>Date|0311039397/06/12/2024|
|Norms Committee Decision:<br>The Committee considered the case as per agenda and taking cue from the earlier decision for same export<br>product/import item in meeting No.NC/3/MEET/May/202526/3  dated  04/06/2025 against advance<br>authorization No.0311032330  dated 19/03/2024 , it was decided to fix ad-hoc norms under Para 4.07 of<br>HBP Vol. I as per details given below or as applied by the firm, whichever is less:-||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


39 

UDIN00566232AM26 

|Export Product|Qty.|Sl. No.|Import Items|Qty. allowed.|
|---|---|---|---|---|
|Ferrous Fumarate BP/USP/FCC|1 kg.|1|Fumaric Acid 99 %|0.725 kg.|

c.in Location: DGFT(HQ) 


39 

UDIN00566232AM26 

|Export Product|Qty.|Sl. No.|Import Items|Qty. allowed.|
|---|---|---|---|---|
|Ferrous Fumarate BP/USP/FCC|1 kg.|1|Fumaric Acid 99 %|0.725 kg.|




|Case No.|60 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|S KANT CHEMICALS PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00004594AM25|
|RA File Number|03AX04004339 AM25|
|Licence No and<br>Date|0311039398/06/12/2024|
|Norms Committee Decision:<br>The Committee considered the case as per agenda and taking cue from the earlier decision for same export<br>product/import item in meeting No.NC/3/MEET/Sep/202425/9  dated  10/10/2024 against Advance<br>Authorization No.3411003006   dated 17/11/2022 , it was decided to fix ad-hoc norms under Para 4.07 of<br>HBP Vol. I as per details given below or as applied by the firm, whichever is less:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>Dexamethasone IP/BP/EP/USP<br>1 kg<br>1<br>16 Alpha-Methyl Epoxide (8DM)<br>0.811 kg.<br>RA concerned may take further necessary action as per above decision of NC.||



|Case No.|61 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|INNOVARE LABS PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


40 

UDIN00566232AM26

|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


40 

UDIN00566232AM26 

|HQ File Number|HQRNORM APPLY 00004600AM25|
|---|---|
|RA File Number|09AX04000824 AM25|
|Licence No and<br>Date|0911008548/06/12/2024|
|Norms Committee Decision:<br>The Committee considered the case as per agenda and taking cue from the earlier decision for same export<br>product/import item in meeting No.NC/3/MEET/Aug/202526/7  dated  22/08/2025 against Advance<br>Authorization No.0911007569  dated 10/07/2024 , it was decided to fix ad-hoc norms under Para 4.07 of<br>HBP Vol. I as per details given below or as applied by the firm, whichever is less:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>7-chloro-5-(2-chlorophenyl)-1,3-<br>dihydro-2H-1,4-benzodiazepin-2-<br>one 4-oxide or Delorazepam-4-<br>oxide (LNO)<br>1 kg.<br>1<br>(2-amino-5-chlorophenyl)<br>(2-chlorophenyl) methanone<br>1.15 kg.<br>RA concerned may take further necessary action as per above decision of NC.||

r Delorazepam-4-<br>oxide (LNO)<br>1 kg.<br>1<br>(2-amino-5-chlorophenyl)<br>(2-chlorophenyl) methanone<br>1.15 kg.<br>RA concerned may take further necessary action as per above decision of NC.||



|Case No.|Case No.|62 / NC/3/MEET/Jan/202526/12|62 / NC/3/MEET/Jan/202526/12|62 / NC/3/MEET/Jan/202526/12|62 / NC/3/MEET/Jan/202526/12|62 / NC/3/MEET/Jan/202526/12|
|---|---|---|---|---|---|---|
|Case Status||Case Approved|||||
|Party Name||KLJ PLASTICIZERS LIMITED.|||||
|Meeting Number<br>and Date||NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|||||
|HQ File Number||HQRNORM APPLY 00004615AM25|||||
|RA File Number||05AX04002962 AM25|||||
|Licence No and<br>Date||0511029473/09/12/2024|||||
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.|||||||
||Export Product||Qty.|Sl. No.|Import Items|Qty. allowed.|

whichever is less**, as per the details indicated below.:-:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.|||||||
||Export Product||Qty.|Sl. No.|Import Items|Qty. allowed.|



|Case No.|Case No.|62 / NC/3/MEET/Jan/202526/12|62 / NC/3/MEET/Jan/202526/12|62 / NC/3/MEET/Jan/202526/12|62 / NC/3/MEET/Jan/202526/12|62 / NC/3/MEET/Jan/202526/12|
|---|---|---|---|---|---|---|
|Case Status||Case Approved|||||
|Party Name||KLJ PLASTICIZERS LIMITED.|||||
|Meeting Number<br>and Date||NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|||||
|HQ File Number||HQRNORM APPLY 00004615AM25|||||
|RA File Number||05AX04002962 AM25|||||
|Licence No and<br>Date||0511029473/09/12/2024|||||
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.|||||||
||Export Product||Qty.|Sl. No.|Import Items|Qty. allowed.|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


41 

UDIN00566232AM26 

|Di Basic Ester (DBE)|1|kg.|1|Di Basic Acid|0.906 kg.|
|---|---|---|---|---|---|
||||2|Methanol|0.488 kg.|

eb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


41 

UDIN00566232AM26 

|Di Basic Ester (DBE)|1|kg.|1|Di Basic Acid|0.906 kg.|
|---|---|---|---|---|---|
||||2|Methanol|0.488 kg.|




|Case No.|63 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|NAVIN FLUORINE ADVANCED SCIENCES LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00004621AM25|
|RA File Number|03AX04004517 AM25|
|Licence No and<br>Date|0311039431/09/12/2024|
|Norms Committee Decision:<br>The committee considered the case as per the agenda and   after examination, it was observed that the firm has not<br>furnished the requisite technical details as prescribed in  Annexture to Appendix 4E. After detailed deliberations and in<br>view of the recommendations of the Technical Authority, the Committee decided to ask the firm to furnish the<br>following documents:<br>End use of export product.<br>1.<br>Percentage yield of reaction at every stage of reaction and over all yield.<br>2.<br>Stoichiometric balance between import and export.<br>3.||



|Case No.|64 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|JODAS EXPOIM PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00004634AM25|
|RA File Number|09AX04000770 AM25|
|Licence No and<br>Date|0911008566/09/12/2024|
|Norms Committee Decision:||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ)

ce No and<br>Date|0911008566/09/12/2024|
|Norms Committee Decision:||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


42 

UDIN00566232AM26 

The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority or as applied for by the firm, **whichever is less** , as per the details indicated below:- 

|Export Product|Qty.|Sl. No.|Import Items|Qty. allowed.|
|---|---|---|---|---|
|Aztreonam lyophilisate for the<br>preparation of solution for<br>inhalation 75 mg.|1 Number|1|Aztreonam|78.75 mg.|




|Case No.|65 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|CADCHEM LABORATORIES LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00004662AM25|
|RA File Number|30AX04000476 AM25|
|Licence No and<br>Date|3011006185/10/12/2024|
|Norms Committee Decision:<br>The Committee considered the case as per agenda and taking cue from the earlier decision for same export<br>product/import item in meeting No.NC/3/MEET/Feb/202223/21  dated  22/02/2023 against Advance<br>Authorization No.0511004617  dated 08/09/2021 , it was decided to fix ad-hoc norms under Para 4.07 of<br>HBP Vol. I as per details given below or as applied by the firm, whichever is less:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty.

was decided to fix ad-hoc norms under Para 4.07 of<br>HBP Vol. I as per details given below or as applied by the firm, whichever is less:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>Citicoline Sodium<br>1 kg.<br>1<br>Cytidine-5-monophosphate<br>(5-CMP)<br>1.25 kg.<br>RA concerned may take further necessary action as per above decision of NC.||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


43 

UDIN00566232AM26 

|Case No.|66 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Rejected|
|Party Name|PRIVI SPECIALITY CHEMICALS LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00004678AM25|
|RA File Number|03AX04004547 AM25|
|Licence No and<br>Date|0311039510/11/12/2024|
|Norms Committee Decision:<br>The firm was initially granted an Advance Authorisation for the export product_“_Galaxmusk Pure_”_under<br>Para 4.07 of the Handbook of Procedures (HBP). However, as per Para 4.11(b) of the Foreign Trade<br>Policy (FTP) 2023, products falling under the category of perfume or perfumery compounds are ineligible<br>for authorisation under Para 4.07 and are mandatorily required to be processed under Para 4.06 of the<br>HBP.<br>It was observed that the firm obtained the authorisation by**misdeclaring that its application was**<br>**covered under the provisions of Para 4.07**, and has not furnished any technical justification/information<br>for the export product.

he authorisation by**misdeclaring that its application was**<br>**covered under the provisions of Para 4.07**, and has not furnished any technical justification/information<br>for the export product. Accordingly, the Committee found no merit in fixing the norms and decided to<br>reject the application.<br>The RA shall ensure that the said authorisation is regularised by recovery of applicable Customs duty<br>along with interest. Further, the RA should also submit a report on how this authorisation was issued<br>under Para 4.07 of HBP, to the Chairperson of the Norms Committee and to PC-4 Section, DGFT<br>Headquarters.<br>The RA concerned may take further necessary action in line with the above decision of the Committee.||



|Case No.|67 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|RUBICON RESEARCH LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00004702AM25|
|RA File Number|03AX04004563 AM25|
|Licence No and<br>Date|0311039546/12/12/2024|
|Norms Committee Decision:||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


44 

UDIN00566232AM26

9546/12/12/2024|
|Norms Committee Decision:||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


44 

UDIN00566232AM26 

The committee considered the case as per the agenda and   after examination, it was observed that the firm has not furnished the requisite technical details as prescribed in  Annexture to Appendix 4E. After detailed deliberations and in view of the recommendations of the Technical Authority, the Committee decided to ask the firm to furnish the following documents: 

1. Copy of Drug Manufacturing Licence (DML). 

2. Copy of Master-Batch Formula for each export product. 

|Case No.|68 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|SALVI CHEMICAL INDUSTRIES LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00004747AM25|
|RA File Number|03AX04004578 AM25|
|Licence No and<br>Date|0311039577/13/12/2024|
|Norms Committee Decision:<br>The committee considered the case as per the agenda and after examination, it was observed that the firm has not<br>furnished the requisite technical details as prescribed in  Annexture to Appendix 4E. After detailed deliberations and in<br>view of the recommendations of the Technical Authority, the Committee decided to ask the firm to furnish the<br>following documents:<br>Complete Chemistry, Chemical Reaction, Stichometric Balance on Molar Basis with Molecular Weight and<br>percentage Yield for  each step of Reaction.<br>i.||

furnish the<br>following documents:<br>Complete Chemistry, Chemical Reaction, Stichometric Balance on Molar Basis with Molecular Weight and<br>percentage Yield for  each step of Reaction.<br>i.||



|Case No.|69 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|DR.REDDY'S LABORATORIES LTD|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00004857AM25|
|RA File Number|09AX04000845 AM25|
|Licence No and<br>Date|0911008629/17/12/2024|
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


45 

UDIN00566232AM26 

or as applied for by the firm, **whichever is less** , as per the details indicated below.:-:

FT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


45 

UDIN00566232AM26 

or as applied for by the firm, **whichever is less** , as per the details indicated below.:-: 

|Export Product|Qty.|Sl. No.|Import Items|Qty. allowed.|
|---|---|---|---|---|
|Liraglutide solution for injection 6<br>mg/ml (18mg/3ml) (Each pre-filled<br>pen contains 3 mL solution of<br>Liraglutide injection which is<br>equivalent to Liraglutide 18 mg)<br>(Pack Size : 1s))|1 Number<br>Injection|1|Liraglutide|19.8 mg.|
|Liraglutide solution for injection 6<br>mg/ml (18mg/3ml) (Each pre-filled<br>pen contains 3 mL solution of<br>Liraglutide injection which is<br>equivalent to Liraglutide 18 mg)<br>(Pack Size : 3s))|1 Number<br>Injection|2|Liraglutide|19.8 mg.|
|Liraglutide solution for injection 6<br>mg/ml (18mg/3ml) (Each pre-filled<br>pen contains 3 mL solution of<br>Liraglutide injection which is<br>equivalent to Liraglutide 18 mg)<br>(Pack Size : 5s))|1 Number<br>Injection|3|Liraglutide|19.8 mg.|



RA concerned may take further necessary action as per above decision of NC

jection which is<br>equivalent to Liraglutide 18 mg)<br>(Pack Size : 5s))|1 Number<br>Injection|3|Liraglutide|19.8 mg.|



RA concerned may take further necessary action as per above decision of NC 

|Case No.|70 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|JUBILANT INGREVIA LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00004895AM25|
|RA File Number|05AX04003211 AM25|
|Licence No and<br>Date|0511029723/19/12/2024|
|Norms Committee Decision:<br>As per the advice of the technical authority, the firm was asked to attend a personal hearing through video<br>conference to explain its case. However, the personal hearing could not be conducted due to technical issues||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


46 

UDIN00566232AM26 

beyond control. In view of this, the Committee decided to provide another opportunity to the firm by conducting the personal hearing through video conference in the ensuing meeting.

N00566232AM26 

beyond control. In view of this, the Committee decided to provide another opportunity to the firm by conducting the personal hearing through video conference in the ensuing meeting. 

|Case No.|Case No.|71 / NC/3/MEET/Jan/202526/12|71 / NC/3/MEET/Jan/202526/12|71 / NC/3/MEET/Jan/202526/12|71 / NC/3/MEET/Jan/202526/12|71 / NC/3/MEET/Jan/202526/12|
|---|---|---|---|---|---|---|
|Case Status||Case Approved|||||
|Party Name||GLENMARK PHARMACEUTICALS LIMITED|||||
|Meeting Number<br>and Date||NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|||||
|HQ File Number||HQRNORM APPLY 00004896AM25|||||
|RA File Number||03AX04004760 AM25|||||
|Licence No and<br>Date||0311039753/19/12/2024|||||
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms. After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty.

inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>1<br>Formoterol Fumarate<br>110.16 gm.<br>Formoterol Fumarate and Fluticasone<br>Propionate Powder for Inhalation ( 12 +<br>250 mcg) 30's ( AIRTEC /<br>COMBIWAVE)(( Net Weight of<br>Formoterol Fumarate is 108.00 Grams<br>and Fluticasone Propionate is 2250.00<br>Grams) )<br>300000<br>Numbers<br>2<br>Fluticasone Propionate<br>2295.0 gm.<br>Glycopyrronium 12.5 mcg and<br>Formotrol Fumarate 12 mcg Powder<br>for Inhalation 30's ( AIRZ - F ) ( Net<br>Weight of Formoterol Fumarate is<br>108.00 Grams) )<br>300000<br>Numbers<br>3<br>Formoterol Fumarate<br>110.16 gm.<br>Glycopyrronium 12.5 mcg and<br>Formotrol Fumarate 12 mcg Powder<br>for Inhalation 15's ( AIRZ - F ) ( Net<br>Weight of Formoterol Fumarate is<br>350000<br>Numbers<br>4<br>Formoterol Fumarate<br>64.26 gm.|||||||
||Export Product||Qty.|Sl. No.|Import Items|Qty.

der<br>for Inhalation 15's ( AIRZ - F ) ( Net<br>Weight of Formoterol Fumarate is<br>350000<br>Numbers<br>4<br>Formoterol Fumarate<br>64.26 gm.|||||||
||Export Product||Qty.|Sl. No.|Import Items|Qty. allowed.|
||Formoterol Fumarate and Fluticasone<br>Propionate Powder for Inhalation ( 12 +<br>250 mcg) 30's ( AIRTEC /<br>COMBIWAVE)(( Net Weight of<br>Formoterol Fumarate is 108.00 Grams<br>and Fluticasone Propionate is 2250.00<br>Grams) )||<br>300000<br>Numbers|1|Formoterol Fumarate|110.16 gm.|
|||||2|Fluticasone Propionate|2295.0 gm.|
||Glycopyrronium 12.5 mcg and<br>Formotrol Fumarate 12 mcg Powder<br>for Inhalation 30's ( AIRZ - F ) ( Net<br>Weight of Formoterol Fumarate is<br>108.00 Grams) )||300000<br>Numbers|3|Formoterol Fumarate|110.16 gm.|
||Glycopyrronium 12.5 mcg and<br>Formotrol Fumarate 12 mcg Powder<br>for Inhalation 15's ( AIRZ - F ) ( Net<br>Weight of Formoterol Fumarate is||350000<br>Numbers|4|Formoterol Fumarate|64.26 gm.|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


47 

UDIN00566232AM26 

63.00 Grams) )

moterol Fumarate|64.26 gm.|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


47 

UDIN00566232AM26 

63.00 Grams) ) 


|Case No.|Case No.|72 / NC/3/MEET/Jan/202526/12|72 / NC/3/MEET/Jan/202526/12|72 / NC/3/MEET/Jan/202526/12|72 / NC/3/MEET/Jan/202526/12|72 / NC/3/MEET/Jan/202526/12|
|---|---|---|---|---|---|---|
|Case Status||Case Approved|||||
|Party Name||DR.REDDY'S LABORATORIES LTD|||||
|Meeting Number<br>and Date||NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|||||
|HQ File Number||HQRNORM APPLY 00004922AM25|||||
|RA File Number||09AX04000851 AM25|||||
|Licence No and<br>Date||0911008669/20/12/2024|||||
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty.

inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>Liraglutide solution for injection 6 mg<br>/ml (18 mg / 3ml) (Each pre-filled pen<br>contains 3 mL solution of Liraglutide<br>injection which is equivalent to<br>Liraglutide 18 mg) (Pack Size : 1s))<br>155871<br>Numbers<br>1<br>Liraglutide<br>19.8 mg/Injection<br>Liraglutide solution for injection 6 mg<br>/ml (18 mg / 3ml) (Each pre-filled pen<br>contains 3 mL solution of Liraglutide<br>injection which is equivalent to<br>Liraglutide 18 mg) (Pack Size : 3s))<br>155871<br>Numbers<br>2<br>Liraglutide<br>19.8 mg/Injection<br>Liraglutide solution for injection 6 mg<br>/ml (18 mg / 3ml) (Each pre-filled pen<br>contains 3 mL solution of Liraglutide<br>72740<br>Numbers<br>3<br>Liraglutide<br>19.8 mg/Injection|||||||
||Export Product||Qty.|Sl. No.|Import Items|Qty.

br>/ml (18 mg / 3ml) (Each pre-filled pen<br>contains 3 mL solution of Liraglutide<br>72740<br>Numbers<br>3<br>Liraglutide<br>19.8 mg/Injection|||||||
||Export Product||Qty.|Sl. No.|Import Items|Qty. allowed.|
||Liraglutide solution for injection 6 mg<br>/ml (18 mg / 3ml) (Each pre-filled pen<br>contains 3 mL solution of Liraglutide<br>injection which is equivalent to<br>Liraglutide 18 mg) (Pack Size : 1s))||155871<br>Numbers|1|Liraglutide|19.8 mg/Injection|
||Liraglutide solution for injection 6 mg<br>/ml (18 mg / 3ml) (Each pre-filled pen<br>contains 3 mL solution of Liraglutide<br>injection which is equivalent to<br>Liraglutide 18 mg) (Pack Size : 3s))||155871<br>Numbers|2|Liraglutide|19.8 mg/Injection|
||Liraglutide solution for injection 6 mg<br>/ml (18 mg / 3ml) (Each pre-filled pen<br>contains 3 mL solution of Liraglutide||72740<br>Numbers|3|Liraglutide|19.8 mg/Injection|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


48 

UDIN00566232AM26 

injection which is equivalent to Liraglutide 18 mg) (Pack Size : 5s))

RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


48 

UDIN00566232AM26 

injection which is equivalent to Liraglutide 18 mg) (Pack Size : 5s)) 


|Case No.|73 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Rejected|
|Party Name|SAPTAGIR LABORATORIES PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00005275AM25|
|RA File Number|09AX04000908 AM25|
|Licence No and<br>Date|0911008741/31/12/2024|
|Norms Committee Decision:<br>The firm was initially granted an Advance Authorisation for the export product_“_CETAGIR_”_under Para<br>4.07 of the Handbook of Procedures (HBP). However, as per Para 4.11(b) of the Foreign Trade Policy<br>(FTP) 2023, products falling under the category of perfume or perfumery compounds are ineligible for<br>authorisation under Para 4.07 and are mandatorily required to be processed under Para 4.06 of the HBP.<br>It was observed that the firm obtained the authorisation by**misdeclaring that its application was**<br>**covered under the provisions of Para 4.07**, and has not furnished any technical justification/information<br>for the export product. Accordingly, the Committee found no merit in fixing the norms and decided to<br>reject the application.<br>The RA shall ensure that the said authorisation is regularised by recovery of applicable Customs duty<br>along with interest.

no merit in fixing the norms and decided to<br>reject the application.<br>The RA shall ensure that the said authorisation is regularised by recovery of applicable Customs duty<br>along with interest. Further, the RA should also submit a report on how this authorisation was issued<br>under Para 4.07 of HBP, to the Chairperson of the Norms Committee and to PC-4 Section, DGFT<br>Headquarters.<br>The RA concerned may take further necessary action in line with the above decision of the Committee.||



|Case No.|74 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


49 

UDIN00566232AM26 

|HQ File Number|HQRNORM APPLY 00005789AM25|
|---|---|
|RA File Number|09AX04000881 AM25|
|Licence No and<br>Date|0911008880/22/01/2025|
|Norms Committee Decision:<br>As per the advice of the technical authority,   the firm was asked to attend a personal hearing through video<br>conference to explain its case. However, the personal hearing could not be conducted due to technical issues<br>beyond control. In view of this, the Committee decided to provide another opportunity to the firm by<br>conducting the personal hearing through video conference in the ensuing meeting.||

issues<br>beyond control. In view of this, the Committee decided to provide another opportunity to the firm by<br>conducting the personal hearing through video conference in the ensuing meeting.||



|Case No.|75 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00005808AM25|
|RA File Number|09AX04000882 AM25|
|Licence No and<br>Date|0911008886/22/01/2025|
|Norms Committee Decision:<br>As per the advice of the technical authority,   the firm was asked to attend a personal hearing through video<br>conference to explain its case. However, the personal hearing could not be conducted due to technical issues<br>beyond control. In view of this, the Committee decided to provide another opportunity to the firm by<br>conducting the personal hearing through video conference in the ensuing meeting.||



|Case No.|76 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|BIOMATRIX HEALTHCARE PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00005847AM25|
|RA File Number|08AX04001762 AM25|
|Licence No and<br>Date|0811013905/24/01/2025|
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


50

irm for fixation of ad-hoc norms . After due deliberation, the||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


50 

UDIN00566232AM26 

Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority or as applied for by the firm, **whichever is less** , as per the details indicated below.:- 

|Export Product|Qty.|Sl. No.|Import Items|Qty. allowed.|
|---|---|---|---|---|
|Doxycycline Capsules BP 100 mg<br>(Ace - Dox) (Net Content - 976 kgs)|9760900<br>Numbers|1|Doxycycline Hyclate<br>EP 8.0 / BP 2014|115.25 mg/100 mg.<br>Capsule|




|Case No.|77 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|FRESENIUS KABI INDIA PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00005926AM25|
|RA File Number|31AX04000396 AM25|
|Licence No and<br>Date|3111004377/29/01/2025|
|Norms Committee Decision:<br>As per the advice of the technical authority,   the firm was asked to attend a personal hearing through video<br>conference to explain its case. However, the personal hearing could not be conducted due to technical issues<br>beyond control. In view of this,  the Committee decided to provide another opportunity to the firm by<br>conducting the personal hearing through video conference in the ensuing meeting.||

ssues<br>beyond control. In view of this,  the Committee decided to provide another opportunity to the firm by<br>conducting the personal hearing through video conference in the ensuing meeting.||



|Case No.|78 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|RUBICON RESEARCH LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00006136AM25|
|RA File Number|03AX04005786 AM25|
|Licence No and<br>Date|0311041215/11/02/2025|
|Norms Committee Decision:||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


51 

UDIN00566232AM26 

The committee considered the case as per the agenda and   after examination, it was observed that the firm has not furnished the requisite technical details as prescribed in  Annexture to Appendix 4E. After detailed deliberations and in view of the recommendations of the Technical Authority, the Committee decided to ask the firm to furnish the following documents:- 

1. Copy of Master-Batch Formula showing net content of inputs in export.

the recommendations of the Technical Authority, the Committee decided to ask the firm to furnish the following documents:- 

1. Copy of Master-Batch Formula showing net content of inputs in export. 

|Case No.|79 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|ANANTA MEDICARE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00006210AM25|
|RA File Number|05AX04003649 AM25|
|Licence No and<br>Date|0511030885/13/02/2025|
|Norms Committee Decision:<br>As per the advice of the technical authority,   the firm was asked to attend a personal hearing through video<br>conference to explain its case. However, the personal hearing could not be conducted due to technical issues<br>beyond control. In view of this, the Committee decided to provide another opportunity to the firm by<br>conducting the personal hearing through video conference in the ensuing meeting.||



|Case No.|80 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|RUBICON RESEARCH LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00006451AM25|
|RA File Number|03AX04006037 AM25|
|Licence No and<br>Date|0311041670/27/02/2025|
|Norms Committee Decision:<br>The committee considered the case as per the agenda and   after examination, it was observed that the firm has not<br>furnished the requisite technical details as prescribed in Annexture to Appendix 4E.

committee considered the case as per the agenda and   after examination, it was observed that the firm has not<br>furnished the requisite technical details as prescribed in Annexture to Appendix 4E. After detailed deliberations and in<br>view of the recommendations of the Technical Authority, the Committee decided to ask the firm to furnish the following<br>documents:<br>Copy of Master-Batch Formula showing net content of inputs in export.<br>1.||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


52 

UDIN00566232AM26 

|Case No.|81 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|ALKYL AMINES CHEMICALS LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00006484AM25|
|RA File Number|03AX04005963 AM25|
|Licence No and<br>Date|0311041736/28/02/2025|
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms. After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>Monoisopropylamine<br>70%<br>Aqueous<br>Solution<br>1 kg.<br>1<br>Isopropyl alcohol<br>0.725 kg.<br>RA concerned may take further necessary action as per above decision of NC.||

r>Qty. allowed.<br>Monoisopropylamine<br>70%<br>Aqueous<br>Solution<br>1 kg.<br>1<br>Isopropyl alcohol<br>0.725 kg.<br>RA concerned may take further necessary action as per above decision of NC.||



|Case No.|82 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|DEEPAK NITRITE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00006815AM25|
|RA File Number|34AX04001096 AM25|
|Licence No and<br>Date|3411006231/21/03/2025|
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms. After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


53 

UDIN00566232AM26 

or as applied for by the firm, **whichever is less** , as per the details indicated below.:- 

|Export Product|Qty.|Sl. No.|Import Items|Qty. allowed.|
|---|---|---|---|---|
|2 Ethyl Hexyl Nitrate|1 kg.|1|2 Ethyl Hexanol|0.748 kg.|
|||2|Nitric Acid 98%|0.386 kg.|

tails indicated below.:- 

|Export Product|Qty.|Sl. No.|Import Items|Qty. allowed.|
|---|---|---|---|---|
|2 Ethyl Hexyl Nitrate|1 kg.|1|2 Ethyl Hexanol|0.748 kg.|
|||2|Nitric Acid 98%|0.386 kg.|




|Case No.|Case No.|83 / NC/3/MEET/Jan/202526/12|83 / NC/3/MEET/Jan/202526/12|83 / NC/3/MEET/Jan/202526/12|83 / NC/3/MEET/Jan/202526/12|83 / NC/3/MEET/Jan/202526/12|
|---|---|---|---|---|---|---|
|Case Status||Case Approved|||||
|Party Name||BENZO CHEM INDUSTRIES PVT LTD|||||
|Meeting Number<br>and Date||NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|||||
|HQ File Number||HQRNORM APPLY 00000062AM26|||||
|RA File Number||03AX04006774 AM25|||||
|Licence No and<br>Date||0311042786/02/04/2025|||||
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms. After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>1<br>2,6-Dichloro toluene<br>(2,6 DCT)<br>1.21 kg.<br>2<br>Sodium methoxide<br>0.412 kg.<br>3<br>Di methyl sulphoxide (DMSO)<br>0.55 kg.<br>3-Chloro 2-Methyl Anisol (3-CMA)<br>or 2-Methoxy 6 Chloro Toluene or 2-<br>Chloro-6-Methoxy Toluene<br>1 kg.|||||||
||Export Product||Qty.|Sl. No.|Import Items|Qty.

l sulphoxide (DMSO)<br>0.55 kg.<br>3-Chloro 2-Methyl Anisol (3-CMA)<br>or 2-Methoxy 6 Chloro Toluene or 2-<br>Chloro-6-Methoxy Toluene<br>1 kg.|||||||
||Export Product||Qty.|Sl. No.|Import Items|Qty. allowed.|
||3-Chloro 2-Methyl Anisol (3-CMA)<br>or 2-Methoxy 6 Chloro Toluene or 2-<br>Chloro-6-Methoxy Toluene||1 kg.|1|2,6-Dichloro toluene<br>(2,6 DCT)|1.21 kg.|
|||||2|Sodium methoxide|0.412 kg.|
|||||3|Di methyl sulphoxide (DMSO)|0.55 kg.|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


54 

UDIN00566232AM26 

|4<br>Dimethyl sulphate<br>0.27 kg.<br>5<br>Hydrochloric acid 30% (HCL<br>30% )<br>0.55 kg.<br>6<br>Sodium hydroxide (Caustic<br>Soda Lye 100%)<br>0.09 kg.<br>RA concerned may take further necessary action as per above decision of NC.|||4|Dimethyl sulphate|0.27 kg.|
|---|---|---|---|---|---|
||||5|Hydrochloric acid 30% (HCL<br>30% )|0.55 kg.|
||||6|Sodium hydroxide (Caustic<br>Soda Lye 100%)|0.09 kg.|

per above decision of NC.|||4|Dimethyl sulphate|0.27 kg.|
|---|---|---|---|---|---|
||||5|Hydrochloric acid 30% (HCL<br>30% )|0.55 kg.|
||||6|Sodium hydroxide (Caustic<br>Soda Lye 100%)|0.09 kg.|




|Case No.|Case No.|84 / NC/3/MEET/Jan/202526/12|84 / NC/3/MEET/Jan/202526/12|84 / NC/3/MEET/Jan/202526/12|84 / NC/3/MEET/Jan/202526/12|84 / NC/3/MEET/Jan/202526/12|
|---|---|---|---|---|---|---|
|Case Status||Case Approved|||||
|Party Name||BENZO CHEM INDUSTRIES PVT LTD|||||
|Meeting Number<br>and Date||NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|||||
|HQ File Number||HQRNORM APPLY 00000064AM26|||||
|RA File Number||03AX04006769 AM25|||||
|Licence No and<br>Date||0311042787/02/04/2025|||||
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms. After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>1<br>Ortho chloro benzyl cynide (OCCN)<br>1.612 kg.<br>2<br>Sodium hydroxide<br>(Caustic Soda Lye 100%)<br>1.27 kg.<br>3<br>Copper sulphate<br>0.035 kg.<br>4<br>Zinc sulphate<br>0.02 kg.<br>2-Coumaranone (2-C)<br>1 kg.|||||||
||Export Product||Qty.|Sl. No.|Import Items|Qty. allowed.|
||2-Coumaranone (2-C)||1 kg.|1|Ortho chloro benzyl cynide (OCCN)|1.612 kg.|
|||||2|Sodium hydroxide<br>(Caustic Soda Lye 100%)|1.27 kg.|
|||||3|Copper sulphate|0.035 kg.|
|||||4|Zinc sulphate|0.02 kg.|

umaranone (2-C)||1 kg.|1|Ortho chloro benzyl cynide (OCCN)|1.612 kg.|
|||||2|Sodium hydroxide<br>(Caustic Soda Lye 100%)|1.27 kg.|
|||||3|Copper sulphate|0.035 kg.|
|||||4|Zinc sulphate|0.02 kg.|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


55 

UDIN00566232AM26 

|5<br>Toluene<br>0.09 kg.<br>6<br>Hydrochloric acid 30% (HCL 30%)<br>2.59 kg.<br>7<br>Sulphuric acid<br>Deleted<br>RA concerned may take further necessary action as per above decision of NC.|||5|Toluene|0.09 kg.|
|---|---|---|---|---|---|
||||6|Hydrochloric acid 30% (HCL 30%)|2.59 kg.|
||||7|Sulphuric acid|Deleted|




|Case No.|Case No.|85 / NC/3/MEET/Jan/202526/12|85 / NC/3/MEET/Jan/202526/12|85 / NC/3/MEET/Jan/202526/12|85 / NC/3/MEET/Jan/202526/12|85 / NC/3/MEET/Jan/202526/12|
|---|---|---|---|---|---|---|
|Case Status||Case Approved|||||
|Party Name||J B CHEMICALS AND PHARMACEUTICALS LIMITED|||||
|Meeting Number<br>and Date||NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|||||
|HQ File Number||HQRNORM APPLY 00000498AM26|||||
|RA File Number||03AX04000346 AM26|||||
|Licence No and<br>Date||0311043334/28/04/2025|||||
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty.

inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>1<br>Cloperastine Fendizoate<br>18.054 mg.<br>Cloperastine Hydrochloride<br>Sugar Free Lozenges 10<br>mg.(Each Lozenge contains (i)<br>Cloperastine Fendizoate 17.70<br>mg (ii) Isomalt ST-M 2685.35<br>mg. Net content (i) 45.87 kg<br>(ii) 6959.40 kg.)<br>1 Number<br>2<br>Isomalt ST-M<br>2539.362 mg.<br>3<br>Cloperastine Fendizoate<br>36.108 mg.<br>Cloperastine Hydrochloride<br>Sugar Free Lozenges 20<br>1 Number|||||||
||Export Product||Qty.|Sl. No.|Import Items|Qty. allowed.|
||Cloperastine Hydrochloride<br>Sugar Free Lozenges 10<br>mg.(Each Lozenge contains (i)<br>Cloperastine Fendizoate 17.70<br>mg (ii) Isomalt ST-M 2685.35<br>mg. Net content (i) 45.87 kg<br>(ii) 6959.40 kg.)||1 Number|1|Cloperastine Fendizoate|18.054 mg.|
|||||2|Isomalt ST-M|2539.362 mg.|
||Cloperastine Hydrochloride<br>Sugar Free Lozenges 20||1 Number|3|Cloperastine Fendizoate|36.108 mg.|
||mg.(Each Lozenge contains (i)||||||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


56 

UDIN00566232AM26 

|Cloperastine Fendizoate 35.40||4|Isomalt ST-M|2539.362 mg.|
|---|---|---|---|---|
|mg (ii) Isomalt ST-M 2666.33|||||
|mg. Net content (i) 47.62 kg|||||
|(ii) 3586.75 kg.)|||||

UDIN00566232AM26 

|Cloperastine Fendizoate 35.40||4|Isomalt ST-M|2539.362 mg.|
|---|---|---|---|---|
|mg (ii) Isomalt ST-M 2666.33|||||
|mg. Net content (i) 47.62 kg|||||
|(ii) 3586.75 kg.)|||||




|Case No.|86 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|NEOGEN CHEMICALS LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000505AM26|
|RA File Number|03AX04000298 AM26|
|Licence No and<br>Date|0311043354/28/04/2025|
|Norms Committee Decision:<br>The committee considered the case as per the agenda and   after examination, it was observed that the firm has not<br>furnished the requisite technical details as prescribed in  Annexture to Appendix 4E. After detailed deliberations and in<br>view of the recommendations of the Technical Authority, the Committee decided to ask the firm to furnish the following<br>documents:<br>(i) Complete Chemistry, Chemical Reaction, Stichometric Balance nn Molar Basis with Molecular Weight<br>and  percentage Yield for  each step of Reaction.||



|Case No.|87 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|USV PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000515AM26|
|RA File Number|03AX04000432 AM26|
|Licence No and<br>Date|0311043393/29/04/2025|
|Norms Committee Decision:||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


57 

UDIN00566232AM26

3393/29/04/2025|
|Norms Committee Decision:||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


57 

UDIN00566232AM26 

The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority or as applied for by the firm, **whichever is less** , as per the details indicated below.:- 

|The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-|The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-|The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-|The Committee examined the request of the firm for fixation of ad-hoc norms .

rom the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-|The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-|The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-|The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-|The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-|The Committee examined the request of the firm for fixation of ad-hoc norms .

rom the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-|The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-|The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-|The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-|
|---|---|---|---|---|---|---|---|---|---|
|<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.||||||||||
||Export Product||Qty.||Sl. No.||Import Items||Qty. allowed.|
|||||||||||
||Ticagrelor Ju|ta 60 mg Tabs|1 Number||1||Ticagrelor Ph. Eur.

<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.||||||||||
||Export Product||Qty.||Sl. No.||Import Items||Qty. allowed.|
|||||||||||
||Ticagrelor Ju|ta 60 mg Tabs|1 Number||1||Ticagrelor Ph. Eur. (ETG)||61.20 mg|
||FTA 168 ST(|(2,000 Cartoon X||||||||
||168 Per Carto|on = 3,36,000||||||||
||Tablets) (Tot<br>Export Produ|al Weight of<br>ct = 20.160 Kgs)||||||||
||(Exempts im|ported||||||||
||input/materia|l weight inclusive||||||||
||of wastage =|23.194 Kgs))||||||||
|||||||||||
||Ticagrelor Juta 60 mg Tabs<br>FTA 56 ST((1,400 Cartoon X<br>56 Per Cartoon = 78,400<br>Tablets) (Total Weight of<br>Export Product = 4.704 Kgs)<br>(Exempts imported<br>input/material weight inclusive<br>f t = 5412 K))||<br>1 Number||2||Ticagrelor Ph. Eur. (ETG)||61.20 mg|
||o wasage  . gs|||||||||
||Til Jt 90  Tb||1 Numb|er|3||Ti|l Ph E (ETG)|918|
||cagreor ua  mg as<br>FTA 168 ST((4,000 Cartoon X<br>168 Per Cartoon = 6,72,000<br>Tablets) (Total Weight of<br>Export Product = 60.480 Kgs)||<br>||||ca|reor . ur.|. mg.|
||(Exempts imported<br>input/material weight inclusive<br>of wastage = 69.582 Kgs))|||||||||
|||||||||||
||Ticagrelor Juta 90 mg Tabs<br>FTA 98 ST((2,500 Cartoon X<br>98 Per Cartoon = 2,45,000<br>Tablets) (Total Weight of<br>Exort Product = 20050 Ks)||1 Numb|er|4||Ticag|relor Ph. Eur. (ETG)|91.8 mg.|
||p   . g<br>(Exempts imported<br>input/material weight inclusive<br>of wastage = 25.369 Kgs))|||||||||
|||||||||||
|RA concerned may take further necessary action as per above decision of NC.||||||||||

g<br>(Exempts imported<br>input/material weight inclusive<br>of wastage = 25.369 Kgs))|||||||||
|||||||||||
|RA concerned may take further necessary action as per above decision of NC.||||||||||





Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


58 

UDIN00566232AM26 

|Case No.|88 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|ARENE LIFE SCIENCES PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000516AM26|
|RA File Number|09AX04000069 AM26|
|Licence No and<br>Date|0911009528/29/04/2025|
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>Raltegravir potassium<br>1 kg.<br>1<br>Benzyl<br>[1-[4-[[(4-fluorobenzyl)<br>amino]<br>carbonyl]-5-hydroxy<br>1methyl<br>6OXO1<br>6<br>Dihydropyrimidin 2YL 1<br>Methylethyl Carbamate<br>1.765 kg.<br>RA concerned may take further necessary action as per above decision of NC.||

no]<br>carbonyl]-5-hydroxy<br>1methyl<br>6OXO1<br>6<br>Dihydropyrimidin 2YL 1<br>Methylethyl Carbamate<br>1.765 kg.<br>RA concerned may take further necessary action as per above decision of NC.||



|Case No.|89 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|LECIPURE BIOTECH LLP|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000519AM26|
|RA File Number|08AX04000140 AM26|
|Licence No and<br>Date|0811014852/29/04/2025|
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


59 

UDIN00566232AM26 

Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority or as applied for by the firm, **whichever is less** , as per the details indicated below.:- 

|Export Product|Qty.|Sl. No.|Import Items|Qty. allowed.|
|---|---|---|---|---|
|Soyabean Lecithin Liquid|48 MT|1|Crude Soyabean Lecithin Liquid|48 MT|

** , as per the details indicated below.:- 

|Export Product|Qty.|Sl. No.|Import Items|Qty. allowed.|
|---|---|---|---|---|
|Soyabean Lecithin Liquid|48 MT|1|Crude Soyabean Lecithin Liquid|48 MT|




|Case No.|90 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000522AM26|
|RA File Number|03AX04000394 AM26|
|Licence No and<br>Date|0311043397/29/04/2025|
|Norms Committee Decision:<br>The Committee considered the case as per agenda and taking cue from the earlier decision for same export<br>product/import item in meeting No.NC/3/MEET/May/202526/3  dated  04/06/2025 against Advance<br>Authorization No.0811013104  dated 29/10/2024 , it was decided to fix ad-hoc norms under Para 4.07 of<br>HBP Vol. I as per details given below or as applied by the firm, whichever is less:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>Indapamide Tablets BP 2.5MG, Each<br>Firm Coated Tablet contains 2.5 mg.<br>(Total 6000000 Tablets) (Net<br>Content Bulk Drug Indapamide EP<br>15.00 kgs ))<br>1 Number<br>1<br>Indapamide EP<br>2.55 mg./Tablet<br>RA concerned may take further necessary action as per above decision of NC.||



Case No. 91 / NC/3/MEET/Jan/202526/12 


Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


60 

UDIN00566232AM26

NC.||



Case No. 91 / NC/3/MEET/Jan/202526/12 


Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


60 

UDIN00566232AM26 

|Case Status|Case Deferred|
|---|---|
|Party Name|SUN PHARMACEUTICAL INDUSTRIES LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000552AM26|
|RA File Number|05AX04000269 AM26|
|Licence No and<br>Date|0511032241/30/04/2025|
|Norms Committee Decision:<br>The committee considered the case as per the agenda and   after examination, it was observed that the firm has not<br>furnished the requisite technical details as prescribed in  Annexture to Appendix 4E. After detailed deliberations and in<br>view of the recommendations of the Technical Authority, the Committee decided to ask the firm to furnish the<br>following documents:-<br>Stepwise complete and balanced chemical reaction with molecular weight.<br>1.<br>Percentage yield on molar basis for each step.<br>2.<br>Material Balance showing requirement and recovery of solvents at each step.<br>3.<br>Consumption-coefficiant for 1 kg. Active Pharmaceutical Ingredient**(**API).<br>4.||

is for each step.<br>2.<br>Material Balance showing requirement and recovery of solvents at each step.<br>3.<br>Consumption-coefficiant for 1 kg. Active Pharmaceutical Ingredient**(**API).<br>4.||



|Case No.|92 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|NEOGEN CHEMICALS LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000561AM26|
|RA File Number|03AX04000419 AM26|
|Licence No and<br>Date|0311043461/01/05/2025|
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below.:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>1<br>Propionyl Bromide<br>0.7515 kg.<br>2-Bromopropionyl Bromide<br>1 kg.<br>2<br>Liquid Bromine<br>0.8705 kg.<br>RA concerned may take further necessary action as per above decision of NC.||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


61 

UDIN00566232AM26

cessary action as per above decision of NC.||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


61 

UDIN00566232AM26 

|Case No.|93 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|VEKO CARE PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000562AM26|
|RA File Number|03AX04000465 AM26|
|Licence No and<br>Date|0311043463/01/05/2025|
|Norms Committee Decision:<br>The committee considered the case as per the agenda and   after examination, it was observed that the firm has not<br>furnished the requisite technical details as prescribed in  Annexture to Appendix 4E. After detailed deliberations and in<br>view of the recommendations of the Technical Authority, the Committee decided to ask the firm to furnish the<br>following documents:<br>(i) Copy of Master batch formula for each export item||

n<br>view of the recommendations of the Technical Authority, the Committee decided to ask the firm to furnish the<br>following documents:<br>(i) Copy of Master batch formula for each export item||



|Case No.|94 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|MANKIND PHARMA LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000567AM26|
|RA File Number|05AX04000357 AM26|
|Licence No and<br>Date|0511032271/01/05/2025|
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>Divalproex Sodium DR CAP USP<br>125 mg.<br>1 Number<br>1<br>Divalproex Sodium USP<br>127.5 mg/Tablet<br>RA concerned may take further necessary action as per above decision of NC.||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


62 

UDIN00566232AM26

cessary action as per above decision of NC.||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


62 

UDIN00566232AM26 

|Case No.|95 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|DEEPAK NITRITE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000577AM26|
|RA File Number|34AX04000070 AM26|
|Licence No and<br>Date|3411006374/01/05/2025|
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>1<br>2 Ethyl Hexanol<br>0.748 kg.<br>2-Ethyl Hexyl Nitrate<br>1 kg.<br>2<br>Nitric Acid (98%)<br>0.386 kg.<br>RA concerned may take further necessary action as per above decision of NC.||



|Case No.|96 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|PIL PHARMACEUTICALS LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000591AM26|
|RA File Number|05AX04000144 AM26|
|Licence No and<br>Date|0511032294/02/05/2025|
|Norms Committee Decision:||



Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 



63

and<br>Date|0511032294/02/05/2025|
|Norms Committee Decision:||



Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 



63 

UDIN00566232AM26 

The committee considered the case as per the agenda and   after examination, it was observed that the firm has not furnished the requisite technical details as prescribed in Annexture to Appendix 4E. After detailed deliberations and in view of the recommendations of the Technical Authority, the Committee decided to ask the firm to furnish the following documents: 

1. Copy of Master-Batch Formula showing net content of inputs in export. 

|Case No.|97 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|ALPHAMED FORMULATIONS PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000594AM26|
|RA File Number|09AX04000032 AM26|
|Licence No and<br>Date|0911009558/02/05/2025|
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>Ulsanic 1 gm. Tablets ((Each<br>Tablet Contains -1000 mg.

the firm,**whichever is less**, as per the details indicated below:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>Ulsanic 1 gm. Tablets ((Each<br>Tablet Contains -1000 mg. of<br>Sucralfate))<br>1 Number<br>1<br>Sucralfate (Aluminium Sucrose<br>Sulphate) (LOD is 11.9% and<br>Aluminium Assay 19.2%)<br>1.02 gm/Tablet<br>Ulsanic 1 gm. Eefervescent<br>Tablets ((Each Effervescent<br>Tablet Contains -1000 mg. of<br>Sucralfate ))<br>1 Number<br>2<br>Sucralfate (Aluminium Sucrose<br>Sulphate) (LOD is 11.9% and<br>Aluminium Assay 19.2%)<br>1.02 gm/Tablet<br>RA concerned may take further necessary action as per above decision of NC.||



|Case No.|98 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|JUBILANT GENERICS LIMITED|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


64 

UDIN00566232AM26 

|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|---|---|
|HQ File Number|HQRNORM APPLY 00000608AM26|
|RA File Number|05AX04000307 AM26|
|Licence No and<br>Date|0511032320/05/05/2025|
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty.

inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>Azithromycin 250mg Film Coated<br>Tablets<br>1 Number<br>1<br>Azithromycin PH. EUR<br>267.26 mg.<br>Azithromycin 500mg Film Coated<br>Tablets<br>1 Number<br>2<br>Azithromycin PH. EUR<br>534.52 mg.<br>RA concerned may take further necessary action as per above decision of NC.||



|Case No.|99 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|MATRIX LIFE SCIENCE PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000609AM26|
|RA File Number|03AX04000503 AM26|
|Licence No and<br>Date|0311043518/05/05/2025|
|Norms Committee Decision:<br>The committee considered the case as per the agenda and   after examination, it was observed that the firm has not<br>furnished the requisite technical details as prescribed in Annexture to Appendix 4E. After detailed deliberations and in<br>view of the recommendations of the Technical Authority, the Committee decided to ask the firm to furnish the<br>following documents:<br>(i) Copy of Master batch formula for each export item||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


65 

UDIN00566232AM26

f Master batch formula for each export item||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


65 

UDIN00566232AM26 

|Case No.|100 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|MANA PHARMA PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000611AM26|
|RA File Number|09AX04001194 AM25|
|Licence No and<br>Date|0911009306/05/05/2025|
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>1<br>2 Ethyl Aniline<br>1.9 kg.<br>2<br>2,3Dihydrofuran<br>1.2 kg.<br>3<br>Toluene<br>2.00 kg.<br>7 Ethyl Tryptophol<br>1 kg.<br>4<br>Hexnae<br>1.00 kg.<br>RA concerned may take further necessary action as per above decision of NC.||



|Case No.|101 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|NICHINO INDIA PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000612AM26|
|RA File Number|09AX04000089 AM26|
|Licence No and<br>Date|0911009569/05/05/2025|
|Norms Committee Decision:||

3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000612AM26|
|RA File Number|09AX04000089 AM26|
|Licence No and<br>Date|0911009569/05/05/2025|
|Norms Committee Decision:||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


66 

UDIN00566232AM26 

The Committee considered the case as per agenda and taking cue from the earlier decision for same export product/import item in meeting No.NC/3/MEET/Sep/202425/9  dated  10/10/2024 against Advance Authorization No.0911004012  dated 24/11/2022 , it was decided to fix ad-hoc norms under Para 4.07 of HBP Vol. I as per details given below or as applied by the firm, whichever is less:- 

|**Export Product**|**Qty.**|**Sl. No.**|**Import Items**|**Qty. allowed.**|
|---|---|---|---|---|
|SOD {N-(1,1-Dimethyl-2-<br>Methylsulfinylethy)-N-{2-Methyl-4-<br>{1,2,2,2- Tetrafluoro-1-<br>{Trifluoromethyl) Ethyl] Phenyl<br>Phthalami (NA)|1 kg.|1|Phthaloyl dichloride (PDC) -98% min.|0.469 kg.|
|||2|2-methyl-1-methylthio-propan-2-amine<br>(SAA) - 95% min.|0.309 kg.|
|||3|2-Methyl-4-heptafluoroisopropyl<br>aniline [RFA]-96% min.|0.5645 kg.|

Phthaloyl dichloride (PDC) -98% min.|0.469 kg.|
|||2|2-methyl-1-methylthio-propan-2-amine<br>(SAA) - 95% min.|0.309 kg.|
|||3|2-Methyl-4-heptafluoroisopropyl<br>aniline [RFA]-96% min.|0.5645 kg.|




|Case No.|102 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|AMNEAL PHARMACEUTICALS PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000625AM26|
|RA File Number|08AX04000168 AM26|
|Licence No and<br>Date|0811014898/05/05/2025|
|Norms Committee Decision:<br>The committee considered the request of firm for fixation of ad-hoc norms and  has been observed that<br>description of export product does not match in line of Drug Manufacturing Licence (DML).  It was<br>decided that the firm may be advised to furnish the justification or submit the copy of DML.||



|Case No.|103 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|M CHEMICALS|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


67 

UDIN00566232AM26

|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


67 

UDIN00566232AM26 

|HQ File Number|HQRNORM APPLY 00000630AM26|
|---|---|
|RA File Number|52AX04000029 AM26|
|Licence No and<br>Date|5211013313/05/05/2025|
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>Schaeffers Acid<br>1 kg.<br>1<br>Beta Naphthol<br>0.74 kg.<br>**Note:**NC also decided to make new SION for the above export product.<br>RA concerned may take further necessary action as per above decision of NC.||



|Case No.|104 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|SWISS PARENTERALS LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000643AM26|
|RA File Number|08AX04000181 AM26|
|Licence No and<br>Date|0811014910/06/05/2025|
|Norms Committee Decision:<br>The committee considered the case as per the agenda and   after examination, it was observed that the firm has not<br>furnished the requisite technical details as prescribed in  Annexture to Appendix 4E.

committee considered the case as per the agenda and   after examination, it was observed that the firm has not<br>furnished the requisite technical details as prescribed in  Annexture to Appendix 4E. After detailed deliberations and in<br>view of the recommendations of the Technical Authority, the Committee decided to ask the firm to furnish the following<br>documents:-<br>Copy of Drug Manufacturing Licence (DML) for the export item.<br>1.<br>Copy of Master-Batch Formula.<br>2.||



Case No. 105 / NC/3/MEET/Jan/202526/12 


Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


68 

UDIN00566232AM26 

|Case Status|Case Status|Case Approved|Case Approved|Case Approved|Case Approved|Case Approved|Case Approved|Case Approved|Case Approved|Case Approved|Case Approved|Case Approved|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Party Name||SENTISS PHARMA PRIVATE LIMITED|||||||||||
|Meeting Number<br>and Date||NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|||||||||||
|HQ File Number||HQRNORM APPLY 00000647AM26|||||||||||
|RA File Number|||||||||||||
||File Number|05AX04000410 AM26|||||||||||
|Lic<br>Dat|ence No and<br>e|0511032377/06/05/2025|||||||||||
|Nor<br>Th<br>pr<br>A<br>H|ms Committee Decision:<br>e Committee considered the case as<br>oduct/import item in meeting No.<br>uthorization No.0511029111 dated 2<br>BP Vol.

2377/06/05/2025|||||||||||
|Nor<br>Th<br>pr<br>A<br>H|ms Committee Decision:<br>e Committee considered the case as<br>oduct/import item in meeting No.<br>uthorization No.0511029111 dated 2<br>BP Vol. I as per details given below o||per agenda<br>NC/3/MEE<br>2/11/2024  <br>r as applie||and takin<br>T/June/2|||g cue from the earlier decision<br>02526/5  dated  30/06/2025 ag||||for same export<br>ainst Advance|
||||||<br>, it was d<br>d by the f|||<br>ecided to fix ad-hoc norms und<br>irm, whichever is less:-||||<br>er Para 4.07 of|
||**Export Product**||**Qty.**|||**Sl.**||**No. **|**Import Items**|||**Qty. allowed.**|
||||||||||||||
||Senticort (Budesonide Nebuliser<br>Suspension 0.5 mg / 2 mL<br> <br>||1 Number|||1|||Budisonide Ph.Eur||0.525 mg.||
||Suspension) in 3 ml Ampoule||||||||||||
||Senticort (Budesonide Nebuliser<br>Suspension 1.0 mg / 2mL<br>||1 Number|||2|||Budisonide Ph.Eur||1.05 mg.||
||Suspension) i|n 3 ml Ampoule|||||||||||
||||||||||||||
||||||||||||||
|RA concerned m||ay take further necessary action as per above decision of NC.|||||||||||
||||||||||||||
||||||||||||||
||||||||||||||
||||||||||||||
||||||||||||||
|Case No.||106 / NC/3/MEET/Jan/202526/12|||||||||||
||||||||||||||
|Case Status||Case Approved|||||||||||
|Party Name||AMNEAL PHARMACEUTICALS PRIVATE LIMITED|||||||||||
|Meeting Number<br>and Date||NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|||||||||||
|HQ|File Number|HQRNORM APPLY 00000648AM26|||||||||||
|RA|File Number|08AX04000176 AM26|||||||||||
|Lic<br>Dat|N d||||||||||||
||nce o an<br>e|0811014921/06/05/2025|||||||||||

d 15/01/2026|||||||||||
|HQ|File Number|HQRNORM APPLY 00000648AM26|||||||||||
|RA|File Number|08AX04000176 AM26|||||||||||
|Lic<br>Dat|N d||||||||||||
||nce o an<br>e|0811014921/06/05/2025|||||||||||
|Nor<br>Th<br>pr<br>A|ms Committee Decision:||||||||||||
||e Committee considered the case as per<br>oduct/import item in meeting No.NC/<br>uthorization No.0811013886  dated 23/0|||agenda and ta<br>3/MEET/Sep/<br>1/2025 , it wa|||king cue<br>202526/<br>s decide|||from the earlier decisio<br>8  dated  17/09/2025<br>d to fix ad-hoc norms u|n for same export<br>against Advance<br>nder Para 4.07 of||



|Case No.|106 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|AMNEAL PHARMACEUTICALS PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000648AM26|
|RA File Number|08AX04000176 AM26|
|Licence No and<br>Date|0811014921/06/05/2025|
|Norms Committee Decision:||
|The Committee considered the case as per agenda and taking cue from the earlier decision for same export||
|product/import|item in meeting No.NC/3/MEET/Sep/202526/8  dated  17/09/2025 against Advance|
|Authorization No.0811013886  dated 23/01/2025 , it was decided to fix ad-hoc norms under Para 4.07 of||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


69 

UDIN00566232AM26 

HBP Vol. I as per details given below or as applied by the firm, whichever is less:-

Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


69 

UDIN00566232AM26 

HBP Vol. I as per details given below or as applied by the firm, whichever is less:- 

|Export Product|Qty.|Sl. No.|Import Items|Qty. allowed.|
|---|---|---|---|---|
|Magnesium Sulfate In Water for Injection<br>(0.325 m Eq Mg++/mL) 40 mg/mL 2g<br>Total|<br> <br>1 Number|1|Magnesium Sulfate<br>Heptahydrate PhEur, USP,<br>Injectable grade|2.00 gm|
|Magnesium Sulfate In Water for Injection<br>(0.325 m Eq Mg++/mL) 40 mg/mL 4g<br>Total|<br> <br>1 Number|2|Magnesium Sulfate<br>Heptahydrate PhEur, USP,<br>Injectable grade|4.00 gm.|




|Case No.|107 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|ALEMBIC PHARMACEUTICALS LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000672AM26|
|RA File Number|34AX04000058 AM26|
|Licence No and<br>Date|3411006410/08/05/2025|
|Norms Committee Decision:<br>The Committee considered the case as per agenda and taking cue from the earlier decision for same export<br>product/import item in meeting No.NC/3/MEET/Mar/202425/19  dated  27/03/2025 against Advance<br>Authorization No.0811011425  dated 02/05/2024 , it was decided to fix ad-hoc norms under Para 4.07 of<br>HBP Vol. I as per details given below or as applied by the firm, whichever is less:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty.

was decided to fix ad-hoc norms under Para 4.07 of<br>HBP Vol. I as per details given below or as applied by the firm, whichever is less:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>Vasopressin<br>Injection<br>USP<br>20<br>units/ml<br>217000<br>Numbers<br>1<br>Vasopressin USP<br>7.958 gm.<br>RA concerned may take further necessary action as per above decision of NC.||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


70 

UDIN00566232AM26 

|Case No.|Case No.|Case No.|108 / NC/3/MEET/Jan/202526/12|108 / NC/3/MEET/Jan/202526/12|108 / NC/3/MEET/Jan/202526/12|108 / NC/3/MEET/Jan/202526/12|108 / NC/3/MEET/Jan/202526/12|108 / NC/3/MEET/Jan/202526/12|108 / NC/3/MEET/Jan/202526/12|108 / NC/3/MEET/Jan/202526/12|
|---|---|---|---|---|---|---|---|---|---|---|
|Case Status|||Case Approved||||||||
|Party Name|||SHREAS INDUSTRIES LIMITED||||||||
|Meeting Number|||||||||||
|and Date|||NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026||||||||
|HQ File Number|||HQRNORM APPLY 00000675AM26||||||||
|RA File Number|||09AX04000077 AM26||||||||
|Licence No and<br>Date|||0911009590/08/05/2025||||||||
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty.

inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>Methylene Chloride (Methylene Di- Chloride<br>/Di-Chloromethane)<br>1 kg.<br>1<br>Methanol<br>0.418 kg.<br>RA concerned may take further necessary action as per above decision of NC.|orms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>r as applied for by the firm,**whichever is less**, as per the details indicated below:-||||||||||
||||||||||||
|||Export Product|||Qty.||Sl. No.|Import It|ems|Qty. allowed.|
||||||||||||
|||Methylene Chloride (Methylene Di-<br>/Di-Chloromethane)||Chloride|1 kg.||1|Metha|nol|0.418 kg.|
||||||||||||
||||||||||||



|Case No.|Case No.|109 / NC/3/MEET/Jan/202526/12|109 / NC/3/MEET/Jan/202526/12|109 / NC/3/MEET/Jan/202526/12|109 / NC/3/MEET/Jan/202526/12|109 / NC/3/MEET/Jan/202526/12|
|---|---|---|---|---|---|---|
|Case Status||Case Deferred|||||
|Party Name||REACH GLOBAL INDIA PRIVATE LIMITED|||||
|Meeting Number<br>||NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|||||
|and Date|||||||
|HQ File Number||HQRNORM APPLY 00000683AM26|||||
|RA File Number||31AX04000035 AM26|||||
|Licence No and<br>||3111004742/08/05/2025|||||
|Date|||||||
|Norms Committee||Decision:|||||

|and Date|||||||
|HQ File Number||HQRNORM APPLY 00000683AM26|||||
|RA File Number||31AX04000035 AM26|||||
|Licence No and<br>||3111004742/08/05/2025|||||
|Date|||||||
|Norms Committee||Decision:|||||
|The committee considered the case as per the agenda and   after examination, it was observed that the firm has not<br>furnished the requisite technical details as prescribed in  Annexture to Appendix 4E. After detailed deliberations and in<br>view of the recommendations of the Technical Authority, the Committee decided to ask the firm to furnish the following<br>documents:-<br>The total weight of imported indigenous raw material comes to 2, 25,000 kg. and then, wastage comes to 8% on<br>net content basis, the same is to be clarified.<br>1.<br>Manufactured process indicating both imported and indigenous items with stage wise wastage.<br>2.|||||||
||Manufactured process indicatin<br>2.||g both import|ed and in|digenous items with stage w|ise wastage.|
||||||||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


71 

UDIN00566232AM26

ous items with stage w|ise wastage.|
||||||||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


71 

UDIN00566232AM26 

|Case No.|110 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|EAST AFRICAN INDIA OVERSEAS|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000685AM26|
|RA File Number|05AX04000315 AM26|
|Licence No and<br>Date|0511032219/08/05/2025|
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>Virexim 1gm (Ceftriaxone<br>Injection 1gm) (Ceftriaxone For<br>Injection 1gm)<br>1 Number<br>1<br>Ceftriaxone Sodium<br>Sterlie USP (As per COA<br>Average Water =<br>8.945, Average Assay?<br>92.248, 92.248 x (100-<br>8.945)/100 = 83.996, API<br>Required for each vial =<br>1000 x 100 / 83.996 =<br>1190.53 plus process loss<br>1.5% = 1208.39 mg each<br>1 gm vial)<br>1.208 gm.<br>RA concerned may take further necessary action as per above decision of NC.||

h vial =<br>1000 x 100 / 83.996 =<br>1190.53 plus process loss<br>1.5% = 1208.39 mg each<br>1 gm vial)<br>1.208 gm.<br>RA concerned may take further necessary action as per above decision of NC.||



|Case No.|111 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|VENUS REMEDIES LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000698AM26|
|RA File Number|30AX04000072 AM26|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


72 

UDIN00566232AM26 

Licence No and 3011006926/08/05/2025 Date Norms Committee Decision: 

The Committee considered the case as per agenda and taking cue from the earlier decision for same export product/import item in meeting No.NC/3/MEET/Oct/202526/9  dated  14/10/2025 against Advance Authorization No.3011006585  dated 27/02/2025 , it was decided to fix ad-hoc norms under Para 4.07 of HBP Vol. I as per details given below or as applied by the firm, whichever is less:-

st Advance Authorization No.3011006585  dated 27/02/2025 , it was decided to fix ad-hoc norms under Para 4.07 of HBP Vol. I as per details given below or as applied by the firm, whichever is less:- 

|Licence No and<br>Date|3011006926/08/05/2025|
|---|---|
|Norms Committee Decision:<br>The Committee considered the case as per agenda and taking cue from the earlier decision for same export<br>product/import item in meeting No.NC/3/MEET/Oct/202526/9  dated  14/10/2025 against Advance<br>Authorization No.3011006585  dated 27/02/2025 , it was decided to fix ad-hoc norms under Para 4.07 of<br>HBP Vol. I as per details given below or as applied by the firm, whichever is less:-<br>Export Product<br>Qty.<br>Sl. No. Import Items<br>Qty. allowed.<br>Ceftriaxone powder for solution for<br>injection 500 mg (Each vial contains:<br>Ceftriaxone Sodium equivalent to<br>ceftriaxone...500 mg)<br>1 Number<br>1<br>Ceftriaxone Sodium<br>Sterile<br>580 mg.<br>Ceftriaxone powder for solution for<br>injection1000 mg (Each vial contains:<br>Ceftriaxone sodium Equivalent to<br>ceftriaxone..1000 mg)<br>1 Number<br>2<br>Ceftriaxone Sodium<br>Sterile<br>1.16 gm.<br>Ceftriaxone powder for solution for<br>injection 2000 mg  (Each vial contains:<br>Ceftriaxone sodium equivalent to<br>ceftriaxone..2000 mg)<br>1 Number<br>3<br>Ceftriaxone Sodium<br>Sterile<br>2.32 gm.<br>RA concerned may take further necessary action as per above decision of NC.||

iaxone sodium equivalent to<br>ceftriaxone..2000 mg)<br>1 Number<br>3<br>Ceftriaxone Sodium<br>Sterile<br>2.32 gm.<br>RA concerned may take further necessary action as per above decision of NC.||




|Case No.|112 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|HI-PURITY CHEMICALS PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000714AM26|
|RA File Number|03AX04000504 AM26|
|Licence No and<br>Date|0311043670/09/05/2025|
|Norms Committee Decision:<br>The Committee considered the case as per agenda and taking cue from the earlier decision for same export||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


73 

UDIN00566232AM26 

product/import item in meeting No.NC/3/MEET/Dec/202526/11  dated  18/12/2025 against Advance Authorization No.0311042741  dated 01/04/2025 , it was decided to fix ad-hoc norms under Para 4.07 of HBP Vol. I as per details given below or as applied by the firm, whichever is less:- 

|**Export Product**|**Qty.**|**Sl. No.**|**Import Items**|**Qty. allowed.**|
|---|---|---|---|---|
|Halquinol|1 kg.|1|8 Hydroxyquinoline|0.77 kg.|

or as applied by the firm, whichever is less:- 

|**Export Product**|**Qty.**|**Sl. No.**|**Import Items**|**Qty. allowed.**|
|---|---|---|---|---|
|Halquinol|1 kg.|1|8 Hydroxyquinoline|0.77 kg.|




|Case No.|113 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|OCTOCHEM PHARMA AND FLAVOURS PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000738AM26|
|RA File Number|05AX04000485 AM26|
|Licence No and<br>Date|0511032477/09/05/2025|
|Norms Committee Decision:||
|The Committee considered the case as per the agenda and observed that the nature of the export item, i.e.,||
|FLAVOURING|ESSENCES , has not been clearly specified in the documents submitted, particularly|
|whether it is intended for use as a perfumery item or as a flavouring agent, which is required for||
|compliance with the provisions(list of ineligible item under self-declaration basis) of Para 4.11 of FTP||
|‑2023.After detailed deliberations and based on the recommendations of the Technical Authority, the||
|Committee decided to direct the firm to furnish the following information:||
|(i) End use of export item supporting by technical documents.||



|Case No.|114 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|OCTOCHEM PHARMA AND FLAVOURS PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


74 

UDIN00566232AM26

|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


74 

UDIN00566232AM26 

HQ File Number HQRNORM APPLY 00000739AM26 RA File Number 05AX04000492 AM26 Licence No and 0511032483/09/05/2025 Date Norms Committee Decision: 

The Committee considered the case as per the agenda and observed that the nature of the export item, i.e., FLAVOURING ESSENCES , has not been clearly specified in the documents submitted, particularly whether it is intended for use as a perfumery item or as a flavouring agent, which is required for 

compliance with the provisions(list of ineligible item under self-declaration basis) of Para 4.11 of FTP 

‑2023. After detailed deliberations and based on the recommendations of the Technical Authority, the Committee decided to direct the firm to furnish the following information: 

(i) End use of export item supporting by technical documents.

sed on the recommendations of the Technical Authority, the Committee decided to direct the firm to furnish the following information: 

(i) End use of export item supporting by technical documents. 

|Case No.|Case No.|115 / NC/3/MEET/Jan/202526/12|115 / NC/3/MEET/Jan/202526/12|115 / NC/3/MEET/Jan/202526/12|115 / NC/3/MEET/Jan/202526/12|115 / NC/3/MEET/Jan/202526/12|
|---|---|---|---|---|---|---|
|Case Status||Case Approved|||||
|Party Name||NICHINO INDIA PRIVATE LIMITED|||||
|Meeting Number and<br>Date||NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|||||
|HQ File Number||HQRNORM APPLY 00000747AM26|||||
|RA File Number||09AX04000090 AM26|||||
|Licence No and Date||0911009606/09/05/2025|||||
|Norms Committee Decision:<br>The Committee considered the case as per agenda and taking cue from the earlier decision for same export<br>product/import item in meeting No.NC/3/MEET/Sep/2024/9  dated 10/10/2024 against advance<br>authorization No.0911004012 dated 24/11/2022 , it was decided to fix ad-hoc norms under Para 4.07 of<br>HBP Vol. I as per details given below or as applied by the firm, whichever is less:-<br>**Export Product**<br>**Qty.**<br>**Sl. No. Import Items**<br>**Qty. allowed.**<br>1<br>Phthaloyl dichloride (PDC) -98%<br>min.<br>0.469 kg.<br>2<br>2-methyl-1-methylthio-propan-2-<br>amine (SAA) - 95% min.<br>0.309 kg.<br>SOD {N-(1,1-Dimethyl-2-<br>Methylsulfinylethy)-N-{2-<br>Methyl-4-{1,2,2,2- Tetrafluoro-1-<br>{Trifluoromethyl) Ethyl] Phenyl<br>Phthalami (NA)<br>1 kg.|||||||
||**Export Product**||**Qty.**|**Sl. No.**|**Import Items**|**Qty.

>Methylsulfinylethy)-N-{2-<br>Methyl-4-{1,2,2,2- Tetrafluoro-1-<br>{Trifluoromethyl) Ethyl] Phenyl<br>Phthalami (NA)<br>1 kg.|||||||
||**Export Product**||**Qty.**|**Sl. No.**|**Import Items**|**Qty. allowed.**|
||SOD {N-(1,1-Dimethyl-2-<br>Methylsulfinylethy)-N-{2-<br>Methyl-4-{1,2,2,2- Tetrafluoro-1-<br>{Trifluoromethyl) Ethyl] Phenyl<br>Phthalami (NA)||<br>1 kg.|1|Phthaloyl dichloride (PDC) -98%<br>min.|0.469 kg.|
|||||2|2-methyl-1-methylthio-propan-2-<br>amine (SAA) - 95% min.|0.309 kg.|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


75 

UDIN00566232AM26 

||3|2-Methyl-4-heptafluoroisopropyl|0.5645 kg.|
|---|---|---|---|
|||aniline [RFA]-96% min.||




|Case No.|116 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|NASENSE LABS PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000748AM26|
|RA File Number|09AX04000088 AM26|
|Licence No and<br>Date|0911009607/09/05/2025|
|Norms Committee Decision:||
|The committee considered the case as per the agenda and   after examination, it was observed that the firm has not||
|furnished the requisite technical details as prescribed in  Annexture to Appendix 4E.

committee considered the case as per the agenda and   after examination, it was observed that the firm has not||
|furnished the requisite technical details as prescribed in  Annexture to Appendix 4E. After detailed deliberations and in||
|view of the recommendations of the Technical Authority, the Committee decided to ask the firm to furnish the||
|following documents:-||
|(i) Complete Chemistry, Chemical reaction, Stichometric balance on Molar basis with Molecular weight||
|and  percentage yield for each step of reaction.||



|Case No.|117 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|OCTOCHEM PHARMA AND FLAVOURS PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000757AM26|
|RA File Number|05AX04000487 AM26|
|Licence No and<br>Date|0511032500/13/05/2025|
|Norms Committee Decision:||
|The Committee considered the case as per the agenda and observed that the nature of the export item, i.e.,||
|FLAVOURING|ESSENCES, has not been clearly specified in the documents submitted, particularly|
|whether it is intended for use as a perfumery item or as a flavouring agent, which is required for||
|compliance with the provisions (list of ineligible item under self-declaration basis) of Para 4.11 of FTP||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


76 

UDIN00566232AM26

self-declaration basis) of Para 4.11 of FTP||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


76 

UDIN00566232AM26 

‑2023. After detailed deliberations and based on the recommendations of the Technical Authority, the Committee decided to direct the firm to furnish the following information: 

(i) End use of export item supporting by technical documents. 

|Case No.|118 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|OCTOCHEM PHARMA AND FLAVOURS PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000758AM26|
|RA File Number|05AX04000489 AM26|
|Licence No and<br>Date|0511032501/13/05/2025|
|Norms Committee Decision:<br>The Committee considered the case as per the agenda and observed that the nature of the export item, i.e.,<br>FLAVOURING ESSENCES, has not been clearly specified in the documents submitted, particularly<br>whether it is intended for use as a perfumery item or as a flavouring agent, which is required for<br>compliance with the provisions (list of ineligible item under self-declaration basis) of Para 4.11 of FTP<br>‑2023.After detailed deliberations and based on the recommendations of the Technical Authority, the<br>Committee decided to direct the firm to furnish the following information:<br>(i) End use of export item supporting by technical documents.||

the recommendations of the Technical Authority, the<br>Committee decided to direct the firm to furnish the following information:<br>(i) End use of export item supporting by technical documents.||



|Case No.|119 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|OCTOCHEM PHARMA AND FLAVOURS PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000759AM26|
|RA File Number|05AX04000484 AM26|
|Licence No and<br>Date|0511032502/13/05/2025|
|Norms Committee Decision:||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


77 

UDIN00566232AM26 

The Committee considered the case as per the agenda and observed that the nature of the export item, i.e., FLAVOURING ESSENCES, has not been clearly specified in the documents submitted, particularly whether it is intended for use as a perfumery item or as a flavouring agent, which is required for compliance with the provisions (list of ineligible item under self-declaration basis) of Para 4.11 of FTP 

‑2023. After detailed deliberations and based on the recommendations of the Technical Authority, the Committee decided to direct the firm to furnish the following information: 

(i) End use of export item supporting by technical documents.

sed on the recommendations of the Technical Authority, the Committee decided to direct the firm to furnish the following information: 

(i) End use of export item supporting by technical documents. 

|Case No.|120 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|OCTOCHEM PHARMA AND FLAVOURS PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000760AM26|
|RA File Number|05AX04000483 AM26|
|Licence No and<br>Date|0511032503/13/05/2025|
|Norms Committee Decision:<br>The Committee considered the case as per the agenda and observed that the nature of the export item, i.e.,<br>FLAVOURING ESSENCES, has not been clearly specified in the documents submitted, particularly<br>whether it is intended for use as a perfumery item or as a flavouring agent, which is required for<br>compliance with the provisions (list of ineligible item under self-declaration basis) of Para 4.11 of FTP<br>‑2023.After detailed deliberations and based on the recommendations of the Technical Authority, the<br>Committee decided to direct the firm to furnish the following information:<br>(i) End use of export item supporting by technical documents.||



|Case No.|121 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|OCTOCHEM PHARMA AND FLAVOURS PRIVATE LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


78 

UDIN00566232AM26

|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


78 

UDIN00566232AM26 

|HQ File Number|HQRNORM APPLY 00000761AM26|
|---|---|
|RA File Number|05AX04000486 AM26|
|Licence No and<br>Date|0511032504/13/05/2025|
|Norms Committee Decision:<br>The Committee considered the case as per the agenda and observed that the nature of the export item, i.e.,<br>FLAVOURING ESSENCES, has not been clearly specified in the documents submitted, particularly<br>whether it is intended for use as a perfumery item or as a flavouring agent, which is required for<br>compliance with the provisions (list of ineligible item under self-declaration basis) of Para 4.11 of FTP<br>‑2023.After detailed deliberations and based on the recommendations of the Technical Authority, the<br>Committee decided to direct the firm to furnish the following information:<br>(i) End use of export item supporting by technical documents.||

the recommendations of the Technical Authority, the<br>Committee decided to direct the firm to furnish the following information:<br>(i) End use of export item supporting by technical documents.||



|Case No.|122 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|AGGARWWAL EXPORTS|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000763AM26|
|RA File Number|05AX04000476 AM26|
|Licence No and<br>Date|0511032512/13/05/2025|
|Norms Committee Decision:<br>The Committee considered the case as per the agenda and, upon detailed examination, observed that the<br>import item_(3R)-3-Hydroxy-4-(Trimethylammonio) Butanoic Acid Inner Salt_appears to be identical to the<br>export product_L-carnitine (Base)_. In view of the apparent identity of the import and export items, the firm<br>is requested to clarify the eligibility of the import item under the norms, supported by relevant technical<br>documents.||



|Case No.|123 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|AGGARWWAL EXPORTS|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


79 

UDIN00566232AM26

|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


79 

UDIN00566232AM26 

|HQ File Number|HQRNORM APPLY 00000764AM26|
|---|---|
|RA File Number|05AX04000478 AM26|
|Licence No and<br>Date|0511032513/13/05/2025|
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>Acetyl-L-Carnitine HCL<br>1 kg.<br>1<br>(3R)-3-Hydroxy-4-(Trimethylammonio)<br>Butanoic Acid Inner Salt)<br>0.715 kg.<br>RA concerned may take further necessary action as per above decision of NC.||



|Case No.|124 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|AGGARWWAL EXPORTS|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000765AM26|
|RA File Number|05AX04000477 AM26|
|Licence No and<br>Date|0511032514/13/05/2025|
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms .

0765AM26|
|RA File Number|05AX04000477 AM26|
|Licence No and<br>Date|0511032514/13/05/2025|
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.<br>L-carnitine L-tartrate<br>1 kg.<br>1<br>(3R)-3-Hydroxy-4-(Trimethylammonio)<br>Butanoic Acid Inner Salt )<br>0.696 kg.<br>RA concerned may take further necessary action as per above decision of NC.||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


80 

UDIN00566232AM26 

|Case No.|125 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Approved|
|Party Name|JUBILANT GENERICS LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00000772AM26|
|RA File Number|05AX04000500 AM26|
|Licence No and<br>Date|0511032546/13/05/2025|
|Norms Committee Decision:<br>The Committee considered the case as per agenda and taking cue from the earlier decision for same export<br>product/import item in meeting No.NC/3/MEET/Jun/202526/5 dated 30/06/205 against Advance<br>Authorization No.0511029526 dated 10/12/2024 , it was decided to fix ad-hoc norms under Para 4.07 of<br>HBP Vol.

ct/import item in meeting No.NC/3/MEET/Jun/202526/5 dated 30/06/205 against Advance<br>Authorization No.0511029526 dated 10/12/2024 , it was decided to fix ad-hoc norms under Para 4.07 of<br>HBP Vol. I as per details given below or as applied by the firm, whichever is less:-<br>**Export Product**<br>**Qty.**<br>**Sl. No.**<br>**Import Items**<br>**Qty. allowed.**<br>Amantadine HCL Tablet 100 mg<br>1 Number<br>1<br>Amantadine<br>Hydrochloride<br>102 mg/100 mg Tablet<br>RA concerned may take further necessary action as per above decision of NC.||



|Case No.|Case No.|126 / NC/3/MEET/Jan/202526/12|126 / NC/3/MEET/Jan/202526/12|126 / NC/3/MEET/Jan/202526/12|126 / NC/3/MEET/Jan/202526/12|126 / NC/3/MEET/Jan/202526/12|
|---|---|---|---|---|---|---|
|Case Status||Case Approved|||||
|Party Name||SARNA CHEMICALS PRIVATE LIMITED|||||
|Meeting Number<br>and Date||NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|||||
|HQ File Number||HQRNORM APPLY 00001693AM26|||||
|RA File Number||52AX04000098 AM26|||||
|Licence No and<br>Date||5211014633/25/06/2025|||||
|Norms Committee Decision:<br>The Committee examined the request of the firm for fixation of ad-hoc norms . After due deliberation, the<br>Committee decided to fix the ad-hoc norms on the basis of inputs received from the Technical Authority<br>or as applied for by the firm,**whichever is less**, as per the details indicated below:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.|||||||
||Export Product||Qty.|Sl. No.|Import Items|Qty. allowed.|

**whichever is less**, as per the details indicated below:-<br>Export Product<br>Qty.<br>Sl. No.<br>Import Items<br>Qty. allowed.|||||||
||Export Product||Qty.|Sl. No.|Import Items|Qty. allowed.|




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


81 

UDIN00566232AM26 

|3-Amino-5-mercapto-1,2,4-triazole|1|kg.|1|Amino|Guanidine|<br>1.86|kg.|
|---|---|---|---|---|---|---|---|
|(AMT)||||Bicarbonate|(AGBC)|||
||||2|Ammonium||1.04|kg.|
|||||Thiocyanate|(AT)|||




|Case No.|127 / NC/3/MEET/Jan/202526/12|
|---|---|
|Case Status|Case Deferred|
|Party Name|INDO AMINES LIMITED|
|Meeting Number<br>and Date|NC/ 3/ MEET/ Jan/ 202526/ 12 and 15/01/2026|
|HQ File Number|HQRNORM APPLY 00002849AM26|
|RA File Number|03AX04002446 AM26|
|Licence No and<br>Date|0311046804/25/08/2025|
|Norms Committee Decision:||
|The committee considered the case as per the agenda and   after examination, it was observed that the firm has not||
|furnished the requisite technical details as prescribed in  Annexture to Appendix 4E. After detailed deliberations and in||
|view of the recommendations of the Technical Authority, the Committee decided to ask the firm to furnish the||
|following documents:-||
|Meaning of<br>1.|IAL in the export description.|
|Certificate of Analysis report of export item.<br>2.||
|Correct Molecular weight of reactants and products with calculation of requirement of imported raw<br>3.||
|material and yield of the reaction.||

icate of Analysis report of export item.<br>2.||
|Correct Molecular weight of reactants and products with calculation of requirement of imported raw<br>3.||
|material and yield of the reaction.||




Digitally Signed. Name: RAMAN KUMAR( Deputy DGFT ) Date: 25-Feb-2026 07:20:06 Reason: ramankumar@nic.in Location: DGFT(HQ) 


82

Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.

Analysis

No analysis generated for this document yet (analysis runs over brief docs + on-demand). Run build_analysis.py --ids 8090 --apply.